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1. Summary 
1.1. English summary 
The decontamination of implant surfaces represents the basic procedure in the management of 
peri-implant diseases, but it still remains a challenge. This study is aimed to evaluate the   
degradation of oral biofilms grown in situ on machined (Ma) and microstructured (MS)     
titanium (Ti) discs through cold atmospheric plasma (CAP). 
Material and Methods  
As many as 400 Ti discs were exposed to the oral cavities of five healthy human volunteers 
for 72 h. The Ti discs were divided randomly between the following treatment groups:      
Untreated biofilms as negative control, four groups treated with CAP (which varied in mean 
power, treatment duration, and/or the gas mixture), and treated biofilms as positive controls 
(gas, diode laser, air-abrasion, chlorhexidine 60 s and chlorhexidine 200 s). The viability, 
quantity, and morphology of control and the treated biofilms were determined by live/dead 
staining, inoculation onto blood agar, quantification of the total protein content, as well as by 
scanning electron microscopy.  
Results 
All the volunteers showed similar colonization patterns of Streptococcus mitis, Streptococcus 
gordonii, Streptococcus constellatus, Actinomyces odontolyticus, Actinomyces viscosus, 
Fusobacterium nucleatum, Viellonella parvula, Eikenella corrodens, and Capnocytophaga on 
the Ma and MS Ti discs. No differences in composition, regarding the colonization of the 
investigated bacteria, were observed between the biofilms accumulated on the Ma and MS Ti 
surfaces. The personal factor and the roughness of the Ti discs played a large role in 
determining the amount of the accumulated biofilms.  
All plasma parameters exhibited great abilities to inhibit bacterial growth on blood agar and 
resulted in a significant decrease in the total amount of biofilms and the average percentage of 
viable bacteria, compared with the untreated control. The treatment of oral biofilms with cold 
atmospheric plasma led to the destruction of the structure of biofilms; it reduced the biofilms 
                                                 
 200 Ma and 200 MS Ti discs, d = 5 mm, h: 1 mm. 
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by the amount as well as by the thickness. Although the superficial bacteria were reduced, a 
complete removal of biofilms was not achieved. There was a correlation between an increase 
in the effectiveness of CAP and an increase in the mean power and/or the treatment duration. 
The antiseptic efficacy of CAP was comparable with diode laser and chlorhexidine. 
No method of diode laser, air-abrasion, and chlorhexidine has been able to completely remove 
the biofilms or has achieved complete inhibition of bacterial growth on blood agar. The 
treatment with air-abrasion, however, exhibited the best ability to eliminate the oral biofilms.  
The SEM analysis of plasma-treated specimens failed to reveal any micromorphologically 
detectable changes of the machined or microstructured titanium surfaces. The highest 
measured temperature on the Ti surfaces reached approximately 52 °C. An increase in the 
measured temperature correlated with the surface roughness, mean power, and the amount of 
biofilms present on the titanium surfaces. 
Conclusion 
The present experimental investigation showed that cold atmospheric plasma has a distinct 
antibacterial efficacy and it is suitable for disintegrating the matured in situ oral biofilms 
formed on machined and microstructured titanium surfaces without causing any thermal or 
mechanical damages. Comparison with other techniques showed that cold atmospheric 
plasma could be compared to diode laser and chlorhexidine 0.2%. 
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1.2. Deutsche Zusammenfassung 
Biofilme sind Ursache der oralen Erkrankungen periimplantäre Mukositis und                   
Peri-implantitis. Die Therapie dieser Erkrankungen stellt eine Herausforderung dar. Das 
aktuelle Therapiekonzept beruht auf der Dekontamination von Implantatoberflächen, die in 
der zahnmedizinischen Praxis jedoch nur unvollkommen möglich ist. Die vorgelegte Arbeit 
hatte das Ziel, orale Biofilme auf maschinierten (Ma) und mikrostrukturierten (MS) 
Titanoberflächen unter Verwendung kalten atmosphärischen Plasmas zu beseitigen. 
Materialien und Methoden  
Vierhundert Titanprüfkörper wurden über 72 h in den Mundhöhlen von fünf gesunden 
Probanden zur Gewinnung oraler Biofilme exponiert. Die biofilmtragenden Prüfkörper 
wurden randomisiert Test- und Kontrollgruppen zugeordnet, bei denen die Oberflächen mit 
unterschiedlichen physikalisch und chemisch antimikrobiell wirksamen Maßnahmen 
behandelt wurden. In den Testgruppen wurden die Biofilme mit physikalischen Plasmen 
unterschiedlicher Intensität und Komposition behandelt.  
Bei der Auswahl der Behandlungsparameter wurde auf biologische Kompatibilität 
hinsichtlich der resultierenden Temperaturen geachtet. Die Biofilme der Kontrollgruppen 
wurden gegenüber Diodenlaser, abrasivem Glycinpulver-Wasser-Gemisch oder Chlorhexidin 
exponiert. Zusätzlich dienten unbehandelte Biofilme und Prüfkörper ohne Biofilme als 
Negativkontrollen.  
Nach der Behandlung wurden die Biofilme morphologisch, quantitativ und hinsichtlich ihrer 
Vitalität im Rasterelektronenmikroskop, mittels Bestimmung der zurückgebliebenen 
Proteinmenge sowie fluoreszenz-vitalmikroskopisch und mikrobiologisch untersucht. 
Ergebnisse 
Es waren bei allen Probanden in den Biofilmen auf maschinierten und mikrostrukturierten 
Titanprüfkörpern die folgenden Mikroorganismen nachweisbar: Streptococcus mitis, 
Streptococcus gordonii, Streptococcus constellatus, Actinomyces odontolyticus, Actinomyces 
viscosus, Fusobacterium nucleatum, Viellonella parvula, Eikenella corrodens and 
Capnocytophaga.  
                                                 
 200 Ma and 200 MS Ti discs, d = 5mm, h: 1 mm. 
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Die Behandlung oraler Biofilme mit kaltem atmosphärischem Plasma führte zur Zerstörung 
der Biofilmstruktur, Biofilmmenge und Biofilmvitalität wurden im Vergleich mit den 
unbehandelten Kontrollen statistisch signifikant reduziert. Erhöhte Plasma 
Bestrahlungsintensität führte zu höherer Reduktion der Biofilmmenge und –vitalität. Eine 
komplette Entfernung von Biofilmen mit ausschließlicher Plasmabehandlung konnte jedoch 
nicht beobachtet werden. Allerdings zeigte auch keine der verwendeten Kontrollmethoden die 
komplette Biofilmentfernung. 
Plasma- und Laserbehandlung von Biofilmen zeigten vergleichbare Ergebnisse hinsichtlich 
residualer Biofilmmenge und –vitalität. Die Nutzung eines abrasiven Pulver-Wasser-
Gemischs führte zur stärksten Reduktion der Biofilmquantität, der verbleibende Biofilm war 
jedoch vital. 
Weder auf maschiniertem noch auf mikrostrukturiertem Titan konnten morphologische 
Oberflächenalterationen nach Plasmabehandlung festgestellt werden. Die höchste gemessene 
Oberflächentemperatur auf Titan erreichte im Zentrum des Plasmajets 52 °C. Ein Aufheizen 
der Prüfkörper wurde nicht beobachtet. 
Zusammenfassung 
Im Vergleich mit klinisch etablierten Methoden der Oberflächendekontamination zeigte die 
Behandlung von oralen 72 h-Biofilmen vergleichbare Ergebnisse hinsichtlich Reduktion und 
Desinfektion. Die Oberflächenstruktur der Titanprüfkörper wurde dabei nicht alteriert.  
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2.  Introduction 
Over the past four decades, dental implantology has devised new solutions and therapy  
choices in dental medicine; in particular, the need to support the functional and cosmetic   
requirements of patients without harming sound tissues adjacent to the edentulous area.  
In recent years, rigorous research has contributed immensely to the improvement of the     
biological acceptance and osseointegration of dental implants. Branemark et al. (1977)      
exhibited the possibility of long-term biological acceptance of dental implants through their 
10-year follow-up study “Osseointegrated implants in the treatment of the edentulous jaw”. 
This study provided a positive concept and opened the way for other clinical research which 
afterward contributed to a variety of discussions and demonstrations of the long-term         
biological acceptance of titanium implants (Adell et al., 1981; Ekelund & Lindquist, 2003; 
Pjetursson et al., 2005; Rasmusson et al., 2005; Lekholm et al., 2006; Jemt & Johansson, 
2006; Astrand et al., 2008). The installation of oral implants has become a routine procedure 
to reconstruct partially and fully edentulous individuals.  
After the installation of an implant into the oral cavity, the already resident microorganisms 
begin to colonize the implant surfaces (Pontoriero et al., 1994; Zitzmann et al., 2000; Lindhe 
& Meyle, 2008). Biofilms are generated by microbial communities developing on the        
interfaces between solid surfaces and biological fluids. Besides microorganisms, biofilms 
consist of a matrix of exopolysaccharides, proteins, and nucleic acids (Hannig & Hannig, 
2009; Marsh, 2006). A lot of diseases in the oral cavity, such as caries, stomatitis, periodontal, 
and peri-implant diseases, are associated with biofilms (Renvert et al., 2009). Experimental 
and clinical studies demonstrated that peri-implant and periodontal tissues react similarly to 
oral biofilms (Berglundh et al., 1992; Ericsson et al., 1992; Pontoriero et al., 1994; Lindhe & 
Meyle, 2008). Also, the removal of biological contamination from dental and implant surfaces 
is one of the most important factors affecting the healing of periodontal and peri-implant   
tissues (Mombelli et al., 1992). 
Therefore, this study highlights the importance of developing new techniques to clean and 
disinfect dental implant surfaces and help to improve the biological properties without having 
any negative effects on the implant surfaces. 
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2.1. Physical Plasma 
Definition  
In physical sciences, plasma is a term which refers to the fourth state of matter. In medicine 
and biology, plasma is known as the non-cellular fluid component of blood (Compton, 1930). 
Physical plasma jet is defined as ionized local gas flows containing a collection of positively 
and negatively charged ions, free electrons, and activated neutral species which act 
collectively (Kieft et al., 2005).  
Plasma can be classified into two types, thermal and non-thermal, based on the differences in 
characteristics. Thermal plasma is the state of fully ionized gas, characterized by a high gas 
temperature and an approximate equality between the gas and electron temperature, and it can 
be generated under atmospheric pressure. The energy content of this plasma is high enough to 
break any chemical bond; therefore, this type of plasma can be excluded from most areas of 
organic chemistry as well as from the field of pharmaceutical science. In contrast, cold plasma 
is mostly characterized by a low gas temperature and a high electron temperature, and it is 
easily generated by electric discharges under reduced pressure (Fridman et al., 2008).  
In all plasmas supported by electric field, electrons receive the external energy faster than the 
heavier ions and have the opportunity to heat up to thousands of degrees before their         
environment heats up. In non-thermal plasma, the cooling of ions and uncharged molecules is 
more effective than energy transfer from electrons, and the gas remains at a low temperature. 
For this reason, non-thermal plasma is also known as non-equilibrium plasma. In thermal 
plasma, on the other hand, the energy flux from electrons to heavy particles equilibrates the 
energy flux from heavy particles to the environment only when the temperature of heavy   
particles becomes almost equal to the electron temperature (Kieft et al., 2005). Sometimes, 
even small differences in the temperature of the heavier species can play a substantial role. 
This is particularly important when various plasma chemical processes are considered. It is 
certainly important when plasma is used to treat heat-sensitive objects.  
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The effectiveness of plasma 
The efficacy of cold atmospheric plasma is manifested through two relevant therapeutic    
effects: physical and biological (Laroussi, 2002; Kieft et al., 2005; Vleugels et al., 2005; 
Manner, 2008; Dobrynin et al., 2009). The physical effects, attained through heating of     
tissues, can induce different effects; they depend not only on the reached temperature of 
plasma, but also on the rate and duration of heating (Manner, 2008). For human tissues, in 
general, no irreversible cellular damage occurs at temperatures below 40 °C. The phenomena 
occurring for temperatures between 40 °C and 50 °C are summarized under the term          
“hyperthermia”. Changes at cellular membranes and molecular structures set in, and the    
interstitial fluid may increase due to water secretion by the cells (oedema formation).         
Depending on the duration of heating, those changes may still be reversible; but after several 
minutes, the tissue may begin to die. At higher temperatures, the cells are irreversibly       
damaged only after a few seconds. Between 60 °C and 80 °C, the denaturation of internal  
proteins occurs first. This process is called coagulation and leads to cell death (necrosis).   
Also, the intercellular proteins then coagulate and transform into gelatin. In addition, the cell 
membranes are destroyed since they contain a large proportion of proteins. At 100 °C, the 
evaporation of the cellular liquid sets in. Additional heat is now converted into the energy of 
evaporation. The vapor pressure leads to mechanical destruction of the tissue. Depending on 
the rate of the heat dissipation, the evaporation either slowly leads to desiccation or violently 
leads to vaporization of the tissue. Only after the evaporation of the entire liquid, the         
temperature can rise beyond 100 °C and the remaining material may burn and thereby induce 
carbonization (Zenker, 2008; Table 1). 
Table 1: Overview of the effects of heating on tissues (modified after Zenker 2008) 
Temperature in tissue Effect 
< 40 °C None 
40-50 °C 
Hyperthermia: changes in cellular membrane and internal molecular structures, 
oedema formation. Time-dependent cell death (necrosis) and devitalisation 
60-80 °C 
Denaturation of the internal proteins (coagulation). Destruction of cell 
membranes. Coagulation of the extracellular collagen. Devitalisation 
100 °C 
Evaporation off cell liquid. Desiccation/Vaporization (depending on heating 
power) 
> 100 °C Carbonization 
Introduction 
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The second therapeutic effect of plasma is biological; it gets through reactive species such as 
oxygen and nitric radicals. The short-living radicals like O and OH are the most important 
sterilizing agents in atmospheric pressure plasma which have more powerful disinfectants and 
stronger oxidation mechanism than ozone (Laroussi, 2002; Kieft et al., 2005). Furthermore, 
ultraviolet irradiation, ions, and electrons are also emitted with the plasma discharges which 
play an important role in enhancing the physical and mechanical effectiveness (Laroussi & 
Leipold, 2004; Vleugels et al., 2005). Lastly, the mechanisms of interaction of reactive 
plasma components with living organisms depend on the way the plasma had been generated 
and delivered, as well as on the organism to which it had been applied (Shimizu et al., 2008; 
Stoffels et al., 2006). 
Cold atmospheric plasma in human medicine 
One of the important medical applications of plasma therapy is tissue coagulation through the 
monopolar electrosurgical technique that uses argon discharges at atmospheric pressure. The 
major application fields are hemostasis, tissue devitalization, and tissue reduction (Hoffmann 
et al., 2012; Manner, 2008; Tsiamoulos et al., 2012). Argon plasma offers a new 
tonsillectomy method which significantly reduces blood loss, surgical time and post-operative 
pain, and help to avoid the general problems associated with electrosurgery (Bergler et al., 
2001). Argon plasma coagulation is effective and safe in the management of gastrointestinal 
vascular lesions, bleeding of the large intestine, and hemorrhagic cystitis (Kwan et al., 2006; 
Quinlan et al., 1992; Villavicencio et al., 2002). 
Devitalization and shrinkage are often used for the treatment of tumors and obstructing 
tissues. In the case of early stage tumors, the desired effect is to kill the cancerous tissues 
which can then be removed mechanically, whenever necessary. If high power is applied, the 
tissue may be carbonized or even vaporized. Examples of devitalization and tissue reduction 
by argon plasma are the treatment of overlarge nasal conches, the minimally invasive 
treatment of tumors, and metastases in the respiratory or gastrointestinal tract (Bergler et al., 
2001). In skin surgery, argon atmospheric plasma is used to treat warts, actinic keratosis, and 
hemangioma (Brand et al., 1998).  
Several in vivo and animal studies have demonstrated that plasma discharges are able to 
accelerate tissue granulation and heal wounds (Zhiliaev et al., 1998). The use of plasma flows 
at the time of surgical treatment of purulent wounds reduces pain during the post-operative 
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period and considerably improves the result of the treatment (Khrupkin et al., 1998). 
Furthermore, experimental studies suggest that NO-containing gaseous flows are useful in the 
treatment of eye wounds and they speed up the healing of cornea erosion and penetrating 
corneal wounds (Gundarova et al., 2001; Chesnokova & Gundorova, 2003). 
The antibacterial effect of non-thermal plasma has been demonstrated by numerous studies 
for a variety of microorganisms (Laroussi, 2002; Lee et al., 2006; Vleugels et al., 2005; Yu & 
Hsieh, 2006; Goree et al., 2006; Sladek et al., 2007; Hübner et al., 2010; Rupf et al., 2010; 
Rupf et al., 2011; Gerspach et al., 2011; Idlibi et al., 2013). However, some studies have 
shown that bacterial DNAs are not completely destroyed by cold plasma (Venezia et al., 
2008; Kim & Kim, 2006). Plasma can also be used to render hydrophilic properties to 
surfaces (Duan et al., 2007; Duske et al., 2012). 
Cold atmospheric plasma in dentistry 
The removal of carious dentin through the plasma technique has been suggested as an 
alternative to the conventional method of drilling (Stoffels et al., 2002; Sladek et al., 2004). 
Ritts et al. (2010) found that the plasma treatment of the peripheral dentin surface increases 
the interfacial bonding strength. 
The methods to decontaminate and condition intraoral surfaces are of great interest in the field 
of dentistry. Only a few papers have dealt with the application of plasma jets for the removal 
and inhibition of in situ oral biofilms. The in vitro disinfection of Streptococcus mutans 
grown on agar plates and in oral biofilms has been demonstrated (Goree et al., 2006; Sladek 
et al., 2007; Rupf et al., 2010). Hauser-Gerspach et al. (2011) investigated the anti-microbial 
efficacy of gaseous ozone on Streptococcus sanguinis and Porphyromonas gingivalis adhered 
to various titanium and zirconia surfaces. Hübner et al. (2010) compared the efficacy of 
chlorhexidine digluconate (0.1%) with that of polihexanide and tissue-tolerable plasma 
against Pseudomonas aeruginosa. The tissue-tolerable plasma led to significant reduction of 
colony-forming units and it was shown to be effective against the Pseudomonas aeruginosa 
biofilms on polystyrene and silicone materials. The microbicidal effect of plasma was      
comparable to that of chlorhexidine digluconate (0.1%).  
  
 
Introduction 
 
- 10 - 
2.2. Peri-implant diseases 
Definition 
The term ‘‘peri-implantitis’’ was first introduced in the late 1980s. It describes the 
pathological changes in soft and hard tissues around a functioning osseointegrated dental 
implant (Mombelli et al., 1987). Peri-implant diseases, in the consensus report of the first 
European Workshop on Periodontology, were divided into a reversible inflammatory reaction 
when the inflammation remains confined to soft tissues, and an irreversible inflammatory 
reaction when the inflammation extends to hard tissues and leads to the loss of the supporting 
bone around the implant (Albrektsson et al., 1994). In the consensus report of the sixth 
European Workshop on Periodontology, the reversible and irreversible form was modified to 
peri-implant mucositis and peri-implantitis, respectively (Lindhe & Meyle, 2008). 
Prevalence 
Roos-Jansåker et al. (2006) reported in a cross-sectional study (216 patients, 987 implants,   
9 to 14 years as functional time) that peri-implant mucositis was diagnosed in 79% of the 
patients and 50% of the implants, while peri-implantitis was diagnosed in 55-77% of the 
patients and 43% of the implants. Fransson et al. (2008) examined 3,413 Branemark implants; 
of them, 12% showed bone loss extended to the apical third of the implant, while clinical 
examination revealed that 94% of the affected implants exhibited bleeding on probing. 
Diagnosis 
Peri-implant mucositis may be identified clinically by redness, swelling, and bleeding on 
probing. In peri-implantitis, the mucosal lesion is associated with the loss of the supporting 
marginal bone and increasing of the peri-implant pocket (Lindhe & Meyle, 2008). 
Peri-implant probing: The presence of bleeding on gentle probing (0.25 N) is a useful        
parameter to diagnose mucosal inflammation. Healthy peri-implant tissues showed absence of 
bleeding on probing, while bleeding on probing occurred in 67% of the patients in the case of 
peri-implant mucositis and 91% of the patients in the case of peri-implantitis (Lang et al., 
1994). Other studies have showed an association between the increase of probing depth and 
loss of the hard tissue around the implant (Lang et al., 1993 and 1994; Schou et al., 1993; 
Zitzmann, 2000; Heitz-Mayfield, 2008).   
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Radiological evaluation: Radiographic techniques, including intra-oral radiography by using 
long cone, paralleling techniques, and panoramic tomography have been widely used to 
monitor marginal bone levels at implants and diagnose interproximal bone loss (Kullman et 
al., 2007). While a panoramic tomograph allows the entire implant to be visualized, its 
limitations, such as image resolution and distortion, are also well known. Further limitations 
of conventional radiography include the inability to monitor facial and lingual/palatal bone 
levels, low sensitivity in the detection of early bone changes, and the underestimation of bone 
loss (Brägger et al., 1988; Akesson et al., 1993; De Smet et al., 2002; Heitz-Mayfield, 2008). 
Recently, multi-slice computer tomography and cone beam volume imaging have been used 
in implant dentistry to the advantage that osseous structures can be represented in three 
planes, true to scale, and without overlay or distortion (Mengel et al., 2006; Heitz-Mayfield, 
2008). 
Implant mobility: The mobility of an implant refers to complete lack of osseointegration and 
the implant should be removed (Heitz-Mayfield, 2008; Fransson et al., 2008). 
Suppuration: The presence of purulent exudates is a result of infection, and it may be 
associated with progressive bone loss and an increase of the peri-implant pocket depth   
(Roos-Jansåker et al., 2006; Fransson et al., 2008).  
Aetiology 
The causative factors of peri-implant diseases are generally divided into two major categories: 
biomechanical and biological (Tonetti, 1999; Klinge et al., 2005; Quirynen et al., 2006). The 
biomechanical factors are associated with functional loads exceeding the implant bone 
interface due to overloading conditions, such as bruising, clenching, and fracture. The 
biological failures are associated with microbial plaque accumulation and bacterial infections, 
as well as sensory disturbances and fibrointegration due to surgical trauma (Tonetti, 1999; 
Esposito et al., 1999; Quirynen, 2002; Klinge et al., 2005; Teughels et al., 2006).  
The biological failures may further be divided into early and late failures. The early failures 
are associated with dental implant infections as a result of contaminated surgical placement or 
impaired host healing (Esposito et al., 1998 and 1999; Snauwaert et al., 2000; Quirynen, 
2002; Norowski & Bumgardner, 2009). Dental implant infections generally occur after more 
than one year of the implant placement and are termed as the plaque-induced peri-implantitis 
(Tonetti, 1999; Quirynen, 2002; Norowski & Bumgardner, 2009). 
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Risk factors of peri-implant disease 
Heitz-Mayfield (2008), in a cross-sectional analysis, investigated the following factors: 
1) Considerable factors associated with peri-implant diseases: poor oral hygiene, history of 
periodontitis, and smoking; 2) Factors that have limited evidence, such as diabetes, poor 
metabolic control, and alcohol consumption; and 3) Factors with conflicting and limited 
evidence, such as implant surface properties and genetic traits.  
Patients with healthy oral hygiene show lower plaque scores and less bleeding on probing 
(Lindquist et al., 1997; Ferreira et al., 2006). Patients with a history of periodontitis show an 
increased risk for peri-implant diseases and peri-implant marginal bone loss, compared with 
healthy periodontal subjects (Hardt et al., 2002; Karoussis et al., 2003; Schou et al., 2006; 
Karoussis et al., 2007; Quirynen et al., 2007). Several studies have referred to an association 
between smoking and development of peri-implant diseases (Haas et al., 1996; Lindquist et 
al., 1996; Lindquist et al., 1997; Carlsson et al., 2000; Feloutzis et al., 2003; Attard & Zarb, 
2002; McDermott et al., 2003; Karoussis et al., 2004; Peñarrocha et al., 2004; Wennström et 
al., 2004; Galindo-Moreno et al., 2005; Nitzan et al., 2005; Schwartz-Arad et al., 2005; 
Strietzel et al., 2007). Lindquist et al. (1997) indicated that smokers with poor oral hygiene 
suffer three times more marginal bone loss than non-smokers. 
The presence of diabetes has been statistically associated with greater risks for                  
peri-implantitis, especially in subjects with poor metabolic control (Ferreira et al., 2006). 
Good oral hygiene is very difficult to achieve around dental restorations without the 
protection of a band of keratinized gingival tissue. A higher plaque accumulation, bleeding 
tendencies on lingual sites, and larger soft-tissue recession on buccal sites were found when 
the width of keratinized mucosa on the peri-implant soft-tissue was lesser than 2 mm (Schrott 
et al., 2009). 
Plaque biofilm as causative factor in the development of peri-implant disease 
The maturation of plaque biofilms on dental and implant surfaces played a major role in the 
development of gingivitis and peri-implant mucositis (Pontoriero et al., 1994). No significant 
differences of clinical and microbiological measures were found between the experimentally 
induced peri-implant mucositis and gingivitis (Löe et al., 1967; Pontoriero et al., 1994).     
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Biofilm formation on dental surfaces 
The formation of plaque biofilms on dental surfaces is a multiple-stage process that begins 
minutes after tooth eruption or cleaning (Gibbons & van Houte, 1973). The enamel gets 
covered by salivary pellicle to form an acellular proteinaceous film on the tooth surface. 
Salivary pellicles are proteins and glycoproteins that selectively bind to tooth surfaces, dental 
implants, restorations, and dental prostheses. The salivary pellicles act as an adhesive binding 
to tooth surfaces, and on the other hand, promote the adhesion and coaggregation of oral 
bacteria (Hannig, 1997; Marsh, 2004).  
Oral bacteria begin to colonize on tooth surfaces within zero to four hours of pellicle 
formation. After formation of the pellicle layer, there begins the weak, long-range 
physicochemical interactions (reversible adhesion) between the pellicle on the tooth surface 
and the cell surface of the oral bacteria, thus encouraging the bacteria to invert their previous 
relation and approach the tooth surface. The weak, long-range interactions transform into 
stronger short-range attachments (irreversible adhesion) within the approach of bacteria to the 
pellicle layer (Marsh, 2006).  
Owing to the fact that many oral microbial species have multiple adhesion types on their cell 
surfaces, they can participate in an excess of interactions simultaneously with other microbes 
and the host surface molecules (Marsh, 2006). Later, other cells adhere to the primary layer of 
bacteria (co-aggregation or co-adhesion) to form multilayered cell clusters in the polymer 
matrix. During the next four to 24 h, the attached bacteria multiply and grow to form distinct 
micro-colonies. Such confluent growth of micro-colonies results in the formation of plaque 
biofilms which increase in complexity over time. The bacterial cells get nutrition from the 
intermicrobial polymer matrix of salivary origin in the supragingival plaque, as well as from 
gingival crevicular fluid and crevicular exudation origin in the subgingival plaque (Marsh, 
2006).   
A large proportion of the initial colonizers are Streptococci (S. sanguis, S. oralis, and S. mitis). 
In one to 14 days, the Streptococcus-dominated plaque changes to a plaque dominated by 
Actinomyces species. In two to four weeks, the bacterial species become more diverse with 
high levels of gram-negative anaerobic filamentous species (Marsh, 2006). 
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Biofilm formation on implant surfaces 
After implantation, bacteria move from saliva, oral tissues, and periodontal pockets, in the 
case of periodontitis, to colonize the implant surfaces (Takanashi et al., 2004; Quirynen et al., 
2006; Heuer et al., 2007). The colonization of implant surfaces starts at irregular 
supragingival areas, and then, spreads down toward the base. The surface irregularities protect 
colonizing bacteria from natural removal forces, e.g. salivary fluid flow and oral hygiene 
measures. The implant-abutment interface may also provide a protected site for bacterial 
accumulation and contribute to the peri-implant inflammatory reactions (Piattelli et al., 1995; 
Quirynen, 2002; Broggini et al., 2006).   
The sequence of biofilm formation on implant surfaces seems to be similar to that of dental 
surfaces. The periopathogenic species of natural dentition and dental implants are essentially 
the same, though there may be some differences in relative numbers and species present 
(Mombelli, 1993; Silverstein et al., 1994; Meffert, 1996; Tanner et al., 1997). The methods of 
Gingival crevicular fluid sampling and DNA probing have shown similarities to biofilm 
microflora on titanium implants and tooth surfaces (Leonhardt et al., 2002). The exposure of 
different implant materials in situ to the oral environment showed that Streptococci were the 
predominant initial colonizing microbes after four hours and that the anaerobes increased 
within 48 h (Nakazato et al., 1989; Rams et al., 1991; Leonhardt et al., 2002; Fürst et al., 
2007). The early colonizers prepare a favorable environment for late colonizers that require 
more demanding growth conditions (Mombelli et al., 1995).  
The putative periodontal pathogens such as Porphyromonas, Prevotella, Capnocytophaga and 
Fusobacterium species are also considered as the causative microbes for peri-implant 
infections (Mombelli & Lang, 1994; Gerber et al., 2006). These pathogens produce endotoxins 
such as collagenase, hyaluronidase, and chondroitin sulphates which elicit an inflammatory 
response, resulting in the loss of supporting bone and tissues around the implant.  
Healthy and infected implants show differences in the composition of the associated 
microbiota (Mombelli et al., 1987 and 1993; Silverstein et al., 1994; Quirynen, 2002; 
Heydenrijk et al., 2002). Successful implants are reported to be populated with the           
gram-positive coccoid cells, very few rods, a low ratio of anaerobe/aerobes, and a low number 
of gram-negative anaerobes (George et al., 1994; Quirynen, 2002). Infected and failing 
implants show greater proportions of the gram-negative anaerobe rods, motile rods, fusiform 
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bacteria, and spirochetes, including large numbers of Fusobacterium ssp, Prevotella 
intermedia, Actinobacillus actinomycetemcomitans, Peptostreptococcus micros, 
Campylobacter rectus, Capnocytophaga spp, and Porphyromonas gingivalis (Mombelli et al., 
1987; Sbordone et al., 1995; Leonhardt et al., 1999; Romeo & Ghisolfi, 2004). 
Effect of roughness on biofilm formation 
Bacterial adhesion and early biofilm formation are significantly influenced by the nanoscale 
morphological features and modifications of implant surfaces (Al-Ahmad et al., 2010; Badihi 
Hauslich et al., 2011; Singh et al., 2011).  
The roughness of implant surfaces is associated with higher incidences of peri-implant 
diseases, especially in the periodontally compromised patient (Wu-Yuan et al., 1995; 
Quirynen et al., 2007). In a scanning electron microscopy study, which was performed to 
evaluate the attachment of oral bacteria on titanium discs with different surface morphologies 
(smooth, grooved, and rough), the highest degree of bacterial attachment was observed on 
rough titanium surfaces, while smooth surfaces showed poor attachment (Rimondini et al., 
1997). The initial biofilm formation and composition were affected by the microtopography 
and hydrophilicity of the surface (Almaguer-Flores et al., 2011).  
The initial bacterial adhesion is primarily influenced by the roughness factor, while the 
influence of surface-free energy seems to be of only minor importance (Bürgers et al., 2010). 
Al-Ahmad et al. (2010) evaluated the biofilm formation on titanium and zirconia implants 
with different roughness degrees in vivo (machined titanium, modified titanium, modified 
zirconia, machined alumina-toughened zirconia, sandblasted alumina-toughened zirconia, and 
machined zirconia); no significant differences were observed in biofilm compositions on the 
different implant surfaces;  the biofilm composition present on the different implant materials 
seems to be similar to that on tooth enamel. The chemical composition of the implant material 
do not have any influence on bacterial behavior once the biofilm has matured, and the 
influence of the surface roughness on the adhesion of microorganisms is compensated by the 
proceeding maturation of the oral biofilm. 
 
 
 
Introduction 
 
- 16 - 
Treatment of peri-implant diseases 
Non-surgical treatment 
Mechanical non-surgical therapy and oral hygiene could be effective in the treatment of     
peri-implant mucositis lesions and the adjunctive use of anti-microbial mouth rinses enhances 
the outcome of mechanical therapy (Renvert et al., 2008 and 2009; Lindhe & Meyle, 2008; 
Thöne-Mühling et al., 2010; Heitz-Mayfield et al., 2011).  
The sub-mucosal debridement of implant surfaces, with increasing peri-implant depth 
(> 5 mm), showed improvement of bleeding score, while a complete removal of all adhering 
microorganisms and peri-implant pockets had not been observed (Lindhe & Meyle, 2008; 
Renvert et al., 2009; Heitz-Mayfield et al., 2011). Antibiotics, antiseptics, and laser 
treatments have been proposed to improve the non-surgical treatment of peri-implantitis 
(Schwarz et al., 2005; Sculean et al., 2005; Schwarz et al., 2006; Kotsovilis et al., 2008; Jan 
Lindhe & Meyle, 2008; Renvert et al., 2008; Renvert et al., 2009; Máximo et al., 2009). 
Surgical treatment  
The surgical treatment of peri-implant lesions aims to facilitate the elimination of all 
granulation tissues from the defect area, debridement and decontamination of implant surfaces 
as well as to render the surface conductive to bone regeneration and reosseointegration 
(Claffey et al., 2008; Lindhe & Meyle, 2008). Schwarz et al. (2006) compared the outcome of 
open and closed debridement of implant surfaces by using different decontamination 
techniques (Er:YAG laser, an ultrasonic device, and plastic curettes with local application of 
metronidazole gel). Regardless of the used decontamination technique, the open debridement 
of implant surfaces improved the outcome of treatment, in comparison with closed 
debridement. Mariano et al. (2011) compared the results of multiple treatments of             
peri-implant diseases. They concluded that surgical therapy was more effective than          
non-surgical approaches in the treatment of peri-implantitis. Regenerative procedures, such as 
bone graft techniques, with or without guided tissue regeneration resulted in various degrees 
of success (Schwarz et al., 2006a; 2006b & 2006c; Lindhe & Meyle, 2008; Mariano et al., 
2011). The resective surgical therapy with modification of the topography of the implant 
surface (removal of the roughness and exposed implant threads) seems to have a positive 
influence on the survival of oral implants affected by peri-implantitis (Romeo et al., 2005 & 
2007).   
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Decontamination of implant surfaces 
The treatment strategy of peri-implant diseases appears to be largely based on the same 
procedures that are used to treat periodontal diseases. The mechanical debridement and the 
surface disinfection represent the basic tenets of these procedures. 
Surface complications of dental implants, such as the screw-shaped designs and surface 
roughness modifications, hinder effective cleaning and biofilm removal from the infected 
implant surfaces. Furthermore, insufficient removal of biological contamination from implant 
surfaces is considered as one of the most important factors which may prevent healing and 
lead to a failure of the conservative and regeneration therapy. Various methods have been 
evaluated, e.g. manual debridement with plastic or titan curets, rotating brush with pumice, air 
powder abrasion, ultrasonic, laser therapy, and application of topical medication such as citric 
acid, chlorhexidine irrigation, peroxide treatment, among others; but none of them was found 
to be the gold standard (Claffey et al., 2008; Lindhe & Meyle, 2008). 
The metal scaler, curettes, and ultrasonic tips led to damages on the titanium surfaces. The 
remaining plaque and calculus did not differ significantly after the treatment with carbon, 
plastic, and metallic scaler tips (Kawashima et al., 2007). Also, the therapy with the vector 
ultrasonic system damages the following implant surfaces: sand-blasted and acid-etched, 
titanium plasma-sprayed, machine-polished, and hydroxyapatite-coated; debris of carbon 
fibers were visible on implant surfaces (Schwarz et al., 2003). Air-abrasion displayed high 
efficacy with regard to biofilm removal (Dennison et al., 1994). 
The irradiation with 980-nm gallium aluminum laser (diode laser) showed reduction of 
bacteria on the machined, sand-blasted, and acid-etched titanium surfaces contaminated with 
Enterococcus faecalis and Porphyromonas gingivalis (Gonçalves et al., 2010). Diode laser 
succeeded in reducing the amount of 10 days in situ oral biofilm formed on titanium surfaces 
(Sennhenn-Kirchner et al., 2007). The irradiation with diode laser effectively reduced the 
viability of the adhered Streptococcus sanguinis and Porphyromonas gingivalis           
(Hauser-Gerspach et al., 2010). Several studies have suggested that diode laser (980 nm) does 
not damage titanium surfaces (Romanos et al., 2000; Theodoro et al., 2003; Castro et al., 
2007; Stubinger et al., 2010; Gonçalves et al., 2010), but may produce a temperature increase 
above the critical threshold (Geminiani et al., 2012). 
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Er:YAG laser was more effective than the ultrasonic system and plastic curettes to remove 
supragingival early plaque biofilms grown on sand-blasted and acid-etched titanium implants 
(Schwarz et al., 2005). The Er:Yag laser application showed cleaning effectiveness on 
different implant surfaces contaminated by Porphyromonas gingivalis (Quaranta et al., 2009). 
Stubinger et al. (2010) reported that the use of Er: YAG laser for implant surface irradiation is 
safe only with the settings no higher than 300 mJ/10 Hz. The irradiation of implant surfaces 
with Er:YAG lasers may produce a temperature increase above the critical threshold (10 °C) 
after 10 s of continuous irradiation (Geminiani et al., 2011).   
Gosau et al. (2010) compared the effect of six different peri-implantitis disinfection methods 
(sodium hypochlorite, hydrogen peroxide 3%, Chlorhexidine gluconate 0.2%, plax, listerine, 
citric acid 40%) on in vivo human oral biofilm for one minute. Sodium hypochlorite, 
hydrogen peroxide, chlorhexidine, and listerine showed a significant bactericidal effect 
against the adhering bacteria. The highest amounts of dead bacteria in proportion to all the 
adhering bacteria were found for sodium hypochlorite, chlorhexidine, and listerine without 
any statistical differences among them. Ntrouka et al. (2011), in a systematic review, reported 
that citric acid is the chemotherapeutic agent with the highest potential to remove biofilms 
from contaminated titanium surfaces in vitro, although it does not achieve complete removal. 
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2.3. Aims of the study 
No single method was found to be superior in decontaminating dental implant surfaces and no 
investigations were available to evaluate cold atmospheric plasma as a technique to remove 
and disinfect in situ oral biofilms on the titanium implant surfaces. On the basis of these 
considerations, the aims of the present research are: 
1. Investigating the influence of cold atmospheric plasma on three-day oral biofilms 
formed on machined and microstructure titanium surfaces. 
2. Comparing the effects of cold atmospheric plasma with diode laser, air-abrasion, and 
chlorhexidine 0.2%. 
3. Testing the effects of cold atmospheric plasma on machined and microstructured 
titanium surfaces (the surface structure and the surface temperature). 
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3. Material and Methods 
3.1. Specimens 
The used specimens are machined (Ma) and microstructured (MS)1 titanium (Ti) discs 5 mm 
diameter and 1 mm thickness (Friadent Germany). Numbers and distribution of groups, 
specimens and treatment parameters are described in Tables (2-a) and (2-b). 
Table 2-a:  The total numbers and distribution of  Ma and MS Ti discs 
Ma MS   Analysing methods                Aim 
5 5 72 h. biofilm ParoCheck  Identify the bacterial species 
5 5 72 h. biofilm Confocal laser microscope Measurement of biofilm thickness   
200 200 72 h. biofilm 10 subgroups (Table 2-b) Plasma treatment and controls 
10 10 clean Cold atmospheric plasma  Studying the surface alterations 
 
Table 2-b:  Description of groups, specimen’s numbers and treatment parameters 
Groups Ti (n) V (n) Time (s) MP Gas d 
Untreated control (UC) 20 Ma + 20 MS 5 ------ ------- ------- ------ 
Gas control (GC) 20 Ma + 20 MS 5 196.25 ------- He  2.0 slm 2 mm
Cold atmospheric plasma pa. 1 (CAP1) 20 Ma + 20 MS 5 196.25 5 W He  2.0 slm 2 mm
Cold atmospheric plasma pa. 2 (CAP2) 20 Ma + 20 MS 5 196.25 3 W He  2.0 slm 2 mm
Cold atmospheric plasma pa. 3 (CAP3) 20 Ma + 20 MS 5 49.06 5 W He  2.0 slm 2 mm
Cold atmospheric plasma pa. 4 (CAP4) 20 Ma + 20 MS 5 49.06 5 W 
He  2.0 slm  
+ O2 5 sccm 
2 mm
Diode laser (DL) 20 Ma + 20 MS 5 60 2.5 W ------- 1 mm
Air-abrasion (AA) 20 Ma + 20 MS 5 60 ------- ------- 5 mm
Chlorhexidin pa. 1 (CHX1) 20 Ma + 20 MS 5 60 ------- ------- 0 mm
Chlorhexidin pa. 2 (CHX2) 20 Ma + 20 MS 5 200 ------- ------- 0 mm
Ti (n): number of titanium discs; V (n): number of volunteers; MP: Mean power; d: distance; slm: standard 
litres per minute; sccm: standard cm per minute 
 
                                                 
1 Sand blasted and acid etched, Ti grade 2, mean roughness (Ra): 1.96 µm, Vickers hardness: 150, tension   
resistance: 470 N/mm², E-module: 110 Gpa. 
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3.2. In situ biofilm formation 
As many as 420 Ti discs (210 Ma and 210 MS) were equally divided between five healthy 
volunteers (aged 20–32 years; three female and two male; Table 2-b). Every 10 Ti discs were 
fixed with silicon impression material1 at the buccal site of the molar and premolar teeth on 
the custom-made maxillary splints (Fig. 1). After 72 h of exposure to the oral cavity, the   
specimens were rinsed for 10 s in a sterile saline solution (0.9%), and then, were checked by 
stereo light microscopy before further processing of the samples.  
 
 
 
 
 
3.3. Study population 
The study protocol was approved by the Ethical Committee of the Saarland Medical 
Association (Vote No. 39/09) and written consents were obtained from all the participants. 
The inclusion criteria for volunteers were: good general health, non-smokers, no antibiotic 
treatment in the last six months, no signs of inflammation of periodontal tissues, and a good 
level of oral hygiene2. The volunteers adapted their regimes of oral hygiene to create 
reproducible amounts of viable biofilms; they stopped using mouth rinses two weeks prior to 
starting the study. They did not use toothpaste and did not brush the Ti surfaces.  
                                                 
1 President light body, Coltene, Switzerland. 
2 Plaque index < 1 ( Loe, 1967): The plaque index was measured at 6 sites  (3 buccal and 3 lingual) of each teeth 
0 =  No plaque. 1 = A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The 
plaque is seen only after passing the probe along the tooth surface. 2 = Moderate accumulation of soft deposit 
within the gingival margin can be seen by the naked eye. 3 = Abundance of soft matter within the gingival 
pocket and / or the tooth and gingival margin. 
Fig. 1: Individual removable custom-made maxillary splints. The Ti discs were fixed with silicon 
impression material at the buccal sites of molar and premolar teeth (a: MS and b: Ma) 
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3.4. Devices 
Cold atmospheric plasma (CAP) 
An experimental plasma source was mounted on a CNC 3-axes linear stage motion system2 
to ensure the reproducible time, distance, and treatment parameters (Rupf et al., 2010). The 
pulse width of the microwave was adjusted at 5 μs and 250 W, which resulted in a plasma jet 
width of ~0.5 mm and a length of 5 mm.  
The treatment was carried out under ambient pressure at a distance of 2 mm between plasma 
jet nozzle and sample surface, and in a meander-like scanning mode line by line with a line 
speed of 1 mm/s or 4 mm/s and a distance between the lines of 0.1 mm (Rupf et al., 2011). 
The basic process gas flow was adjusted to 2 standard liters per minute (slm) helium for all 
the four CAP parameters. For CAP4, oxygen was admixed 5 standard cm per minute 
(sccm)3.  
The evaluated CAP variables were the mean power (3 or 5 W), the line speed of scanning 
(CAP1 and CAP2: 1mm s-1 or CAP3 and CAP4: 4mm s-1), and the process gas (an O2 
admixture). 
 
 
 
 
 
 
 
                                                 
 Leibniz Institute of Surface Modification, Leipzig, Germany. 
2 Steinmeyer MC-G047, Feinmess Dresden GmbH, Germany. 
3 Mass flow controllers, Bronkhorst, Ruurlo, The Netherlands. 
Fig. 2: The drawing describes the plasma source and specimens’ treatment 
Plasma jet source on 
3-axis motion system 
2.45 GHz Microwave 
Pulse-generator 
Plasma jet nozzle 
Titanium specimen 
The distance between plasma jet 
nozzle and sample surface (2 mm) 
Scanning mode with a step 
width of 0.1 mm 
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The operational temperatures for all CAP parameters were measured dynamically by the 
means of infrared thermography1 on the surfaces of the Ti discs and were performed at room 
temperature with a thermal resolution of ±0.1 °C, an optical frame of 160 × 120 pixels, and a 
frame rate of 100 Hz (Rupf et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 Optris PI, Optris GmbH, Berlin, Germany. 
 
Fig. 3: The drawing describes the plasma source, specimens and thermography 
infrared-camera 
Fig. 4: a: Plasma source and b: Thermography infrared-camera 
Thermography infrared-camera 
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Diode Laser 
The laser treatment was applied in a scanning mode by using a diode laser1, set at a mean 
power of 2.5 W, and pulse repetition of 25 ms pulse and a pause of 50 ms (Fig. 5, Table 2-b). 
 
 
 
 
  
 
Air-abrasive powder  
The air-abrasion treatment was performed in a circular motion by using a dental powder   
blaster (PROPHYflex 2, KaVo) and amino acid glycine powder (Fig. 6, Table 2-b). 
Chlorhexidine 
The specimens were submerged in a 200 µl chlorhexidine digluconate solution 0.2%2  
(Fig. 7) for 60 s (CHX1) or for 200 s (CHX2) (Table 2-b). 
 
 
 
 
 
 
                                                 
1 980 nm, GENTLEray 980 classic, KaVo, Biberach, Germany. 
2 Chlorhexamed® forte 0.2% GlaxoSmithKline, Munich, Germany. 
 
Fig. 5: a: Diode laser device, b: Laser treatment of Ma Ti discs (left) and MS Ti discs (right) 
Fig. 7: Chlorhexamed® forte 0.2% GlaxoSmithKline Fig. 6: Left: Air-flow Perio Subgingival. 
Right: Prophyfex 2, KaVo 
Material and Methods 
  
- 25 - 
Fig. 8: Fluorescence microscope 
3.5. Analysis of biofilm 
ParoCheck analysis  
ParoCheck1 is a commercial microarray system that allows simultaneous detection of up to 
20 different oral bacterial species, based on species-specific highly conserved regions, from 
the 16S rRNA gene (Eberhard et al., 2008). The Ti discs were assayed in a 20 µl reaction 
mixture containing 1 µl template, 0.2 µl Taq DNA polymerase, and 18.8 µl master mix     
supplied with the Parocheck kit2. The DNA preparation was performed directly from the  
plaque biofilms accumulated on the Ti discs and carried out in accordance with the               
manufacturer’s instructions.3 
Live/dead staining  
 Live/dead staining is a technology that permits quantitative 
distinguishing between live and dead bacteria. The live/dead 
kit4 consists of two stains, green (SYTO®9) and red (propidium 
iodide), which differ in their abilities to penetrate bacterial cells 
and stain nucleic acids. The acid’s green fluorescing is able to 
enter every cell, while the red fluorescing only enters the cells 
with damaged cytoplasmic membrane and can reduce SYTO® 9 
fluorescence when both dyes are present. Thus, live bacteria 
with intact membranes have only SYTO® 9 and fluoresce green, while dead bacteria with 
damaged membranes have both the dyes but fluoresce red.  
The stain was prepared by diluting X µl of SYTO 9 and X µl of propidium iodide in X ml of 
distilled water. The specimens were placed in 48 well plates and 100 µl of the reagent mixture 
were added to each of them, followed by incubation, at room temperature, in the dark, for 
15 min. Each of the specimens was carefully positioned on a glass slide, and covered with 
mounting oil and stored in a dark space at 4 °C until further processing. The samples were 
                                                 
1 ParoCheck®; Greiner Bio-One GmbH, Frickenhausen, Germany. 
2 ParoCheck kit containing buffers, MgCl2, dNTPs, DNase-free water and fluorophore-labeled primers. 
3 The analysis was carried out by Dr. med. Rita Grigorean, IGD Saar GmbH, Zentrum für Innovative           
Genetische Diagnostik, Homburg, Deutschland. 
4 Back Light Bacterial Viability Kit L7012, Molecular Probes, Carlsbad, USA. 
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Fig. 9: Agar Rodac plates 
evaluated under a reverse light fluorescence microscope1 (Fig. 8), equipped with a digital 
camera2 and filter sets, by using the image processing software AxioVision 4.83. Five     
images were taken at 100 × magnification from the center and the four quarters of the        
specimen. Live/dead images of the Ti surfaces were separated to red and green color        
channels, and the median areas of the red and green fluorescence were calculated. Lastly, the 
green fluorescence values were expressed as a percentage of the red fluorescence (Rupf et al., 
2011; Idlibi et al., 2013). 
To determine the thickness of the biofilms, five Ma and five MS Ti discs were explored by 
CLSM4. For this purpose, the biofilms were analyzed by using a 10 × 63 oil immersion 
objective. Each biofilm was scanned at four representative areas. The Z-series of optical 
sections were generated by vertical sectioning at 6 µm distances through the biofilms. Image 
analysis and biofilm thickness measurement were performed by using the LSM software ZEN 
2008 (Zeiss). 
Microbiology 
The viability of biofilms was tested by contact inoculation of the 
treated and untreated Ti plates with universal brain heart infusion 
blood agar (Rodac plates)5. Then, the Rodac plates were 
incubated at 37 °C (5% CO2) for 24 h. 
After 24 h, the plates were pictured and the impression area of each specimen on the blood 
agar was classified as positive (presence of colonies) or negative (no colonies detected). Also, 
each impression area was analyzed by using the image-J software to calculate: 1) The colony 
area; and 2) The colony-free area. 
 
 
                                                 
1 Leitz DMR, Leica, Wetzlar, Germany. 
2 AxioCam MRm Rev. 3, Carl Zeiss Microlmaging, Goettingen, Germany. 
3 Carl Zeiss Microlmaging, Goettingen, Germany. 
4 Confocal laser scanning microscopy; Zeiss LSM 710, Carl Zeiss MicroImaging GmbH, Jena, Germany. 
5 BHI, Sigma-Aldrich, Taufkirchen, Germany. 
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Detection of total protein  
The specimens were transferred to a fresh 2 ml Eppendorf tube, and overlaid with 50 µl of 
RIPA buffer1 and sonicated for 10 min at 4 °C; then 100 µl d H2O as well as 150 µl of Micro 
BCA working reagent were added to it; finally, the samples were incubated at 55 °C for 
60 min.  
Standard protein solutions (albumin) from 0-100 µg/ml were prepared and treated identically 
to the samples. The absorbance of protein standard and treated specimens was measured at 
562 nm in a multifunctional microplate reader2 by tenfold determination of each well. Total 
protein content of the biofilms was calorimetrically estimated (Micro BCA assay, Pierce 
Biotechnology, Rockford, IL, USA).  
 
 
           
 
 
 
Scanning electron microscopy (SEM)  
The controlled and treated Ti discs were washed gently 
with phosphate buffer saline (PBS) to remove the cells 
not attached to the surface and fixed in glutaraldehyde3 
for 2 h; afterward, they were rinsed five times for 10 min 
in PBS.  
 
                                                 
1 150 mM NaCl, 1.0% Octylphenyl-polyethylene glycol, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris,    
pH 8.0, Sigma-Aldrich, Steinheim, Germany. 
2 Tecan Infinite 200, Magellan V6.6, Tecan, Grödig, Austria. 
3 2.5% in phosphate buffered saline (PBS); PAA Laboratories GmbH, Pasching, Austria. 
Fig. 10: From left to right: a: Bandelin Sonorex device, b: 96 Well Microplate, c: Tecan Infinite m200  
Fig. 11: Scanning electron microscope 
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Subsequently, the samples were dehydrated in an increasing series of ethanol (50–90% 
10 min each; then 100% 3 X 15 min). Finally, the samples were dried in 1,1,1,3,3,3-
hexamethyl-disilazane1. HMDS was vaporized at room temperature in a clean bench. All the 
samples were mounted on the SEM-sample stubs and sputtered with platinum. The SEM 
analysis was carried out in a FEI XL30 ESEM FEG2 at magnifications of 50, 1000, 5000, 
and 10000. The Ti surfaces were scanned to investigate residual biofilm, bacteria, and 
structural changes of biofilm and surface alterations caused during the treatment. 
3.6. Statistical analysis 
400 Ti discs (200 Ma and 200 MS) were equally divided between 20 groups (10 Ma and 10 
MS), which 20 biofilm specimens were assigned to each group (Table 2-b). All analyzes 
(live/dead, microbiology, detection of total protein, and scanning electron microscopy) were 
conducted five times.  
The data were analyzed by using the SPSS software (SPSS statistics base 17.0, Chicago, 
USA) as follows: 1) All the values were expressed as mean and standard deviation. 2) Each of 
the treated groups (GC, CAP1, CAP2, CAP3, DL, AA, CHX1, and CHX2) was compared 
with the untreated control by using Student t-test (two-tailed, independent). 3) One way 
Analysis of Variance (ANOVA) followed by Sidak post hoc test was used to compare the 
means of the four plasma-treated groups (CAP1, CAP2, CAP3, and CAP4). 4) Base on the 
treatment duration, repeated measures were employed for comparison of plasma groups with 
the positive control groups (CAP1 (196.25 s) was compared to CHX2 (200 s), and CAP3 
(49.04 s) was compared to DL (60 s), AA (60 s), and CHX1 (60 s)) by using Student t-test 
(two-tailed, independent). For all comparison p < 0.05 was considered statistically significant. 
 
 
 
                                                 
1 HMDS, Acros Organics, Geel, Belgium. 
2 FEI Company, Eindhoven, The Netherlands. 
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4. Results 
4.1. Surface analysis of Ti discs 
The Ma Ti discs showed small formations (Fig. 12-a). The SEM micrographs of the MS Ti 
discs were processed by using a 3D image reconstruction software (Alicona MeX 5.1) to 
analyze the roughness, height, and profile of the MS Ti discs. The microstructures had a mean 
roughness of 2.04 µm, average height of profile 1.2 µm, and the maximum measured distance 
between the highest and the lowest level reached 21.3 µm (Figs. 12-b and 13, Table 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Profile analysis using a 3D image reconstruction software (Alicona MeX 5.1) 
MS Ti discs 1 2 3 4 5 6 M SD 
Pa; average height of profile 1.7 1.4 1.4 1.5 1.7 2.2 1.6 0.3 
Pt; maximum peak to valley height of profile 31.1 16.7 24.4 15.5 16.1 24.3 21.4 6.3 
Ra;  average roughness of profile 2.1 2.1 2 1.9 2.1 2 2 0.1 
Rt; maximum peak to valley roughness of profile 11.1 7.9 9.9 7.6 9.2 8.3 2.1 1.3 
Fig. 13: 3D horizontal (a) and lateral (b) colure reconstruction surface profiles of the MS Ti discs (SEM 
data, visualized by using 3D image reconstruction software (Alicona MeX 5.1)) 
Fig. 12: The SEM micrographs of the Ma Ti discs (a) and the MS Ti discs (b) at 10000 X magnification 
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4.2. Analysis of three days in situ oral biofilm  
The SEM results showed that all the MS Ti discs (one of each volunteer) were entirely filled 
up with biofilm, while only two Ma Ti discs (two volunteers) showed surfaces entirely 
covered with biofilms; one specimen was covered approximately 80% and the last two 
specimens were covered approximately 60%. The center and the edge of the MS and Ma Ti 
discs had always thicker biofilm accumulation as in the middle (Figs. 17-a1 and 17-b1).  
100 X 10 mag. FM and 10000 SEM micrographs showed domination of cocci-shaped bacteria 
(Figs. 15 a1-a3 and b1-b3, Figs. 17-a3 and 17-b3). The lower layers had only cocci-shaped 
bacteria, while bacilli-shaped bacteria were visible in the upper layers of the biofilms, 
especially on the MS Ti discs (Fig. 16-b1, CLSM results). 
There was significant differences between the amount of the accumulated biofilms on the MS 
and Ma Ti discs p = 0.0003, the amount of the accumulated biofilms on the MS Ti discs 
(54.6 + 10.4 µg) exceeded twice the amount of the biofilms accumulated on the Ma Ti discs 
(22.2 + 5.1 µg).  
The proportion of red fluorescent was slightly more on the MS discs as the Ma discs’ 
p = 0.225. All contact inoculation of the MS and Ma discs showed bacterial growth to cover 
the entire impression area on blood agar, but the bacterial colonies of the MS discs were    
larger and showed more proliferation than the Ma Ti discs.  
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Fig. 14: Comparison between the accumulated biofilms on the Ma (light colour) and the MS 
Ti discs (dark colour) 
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The ParoCheck analysis showed the domination of cocci-positive gram bacteria, but 
anaerobia, negative gram, and bacilli are also present. The following species were detected in 
the 72 h in situ oral biofilms: Streptococuss mitis, Streptococuss gordonii, Streptococuss 
constellatus, Viellonella parvula, Eikenella corrodens, Capnocytophaga sp, Actinomyces 
odontolyticus, Fusobacterium nucleatum, Actinomyces viscosus, and only by one volunteer 
the Peptostreptococcus micros (Table 4). 
Table 4: The detected pathogens on Ma and MS Ti discs of 72 h old oral biofilms (ParoCheck analysis) 
Bacteria MS Ma Description of Bacteria 
Streptococuss 
 mitis group 
(+, +, +, +, +) (+, +, +, +, +) 
Gram positive, facultative anaerobe, are part of the oral flora, 
usually arranged in short chains in the shape of cocci. 
Streptococuss 
gordonii group 
(+, +, +, +, +) (+, +, +, +, +) 
Gram positive, grow in pairs or bead like chains, are integral 
members of the human oral flora and plays an integral role in 
initiating colonization for other colonizers to adhere to biofilm. 
Viellonella parvula (+, +, +, +, +) (+, +, +, +, +) Gram negative cocci, anaerobe are part of the oral flora. 
Eikenella 
corrodens 
(+, +, +, +, +) (+, +, +, +, +) 
Gram negative facultative anaerobic bacillus. It grows in aerobic 
and anaerobic conditions. 
Streptococuss  
constellatus group 
(+, +, +, +, +) (+, +, +, +, +) 
Gram positive, part of the human oral normal flora, The cells are 
small, normally 0.5-1μm in diameter and form short chains. 
Capnocytophaga   
sp 
(+, +, +, +, +) (+, +, +, +, +) 
Gram-negative bacteria, normally found in the oropharyngeal 
tract of mammals, they are involved in the pathogenesis of some 
animal bite wounds as well as periodontal diseases. 
Actinomyces 
odontolyticus 
(+, +, +, +, +) (+, +, +, +, +) 
Gram positive, rod shaped bacilli, anaerobe, part of the human 
oral normal flora. 
Fusobacterium 
nucleatum 
(+, +, +, +, +) (+, +, +, +, +) 
Gram-negative, rod shaped bacilli, anaerobic. It is a key 
component of periodontal plaque due to its abundance and its 
ability to coaggregation with other species in the oral cavity. 
Actinomyces  
viscosus 
(-, -, +, -, +) (-, -, +, -, +) 
Gram-positive, is part of the human oral flora, rod-shaped 
filamentous bacteria, occurs in high numbers in the dental plaque, 
cemental caries, and tonsillar crypts. 
Peptostreptococcus 
micros 
(-, -,  -, -, -) (-, -, -, +, -) 
Gram-positive, anaerobic. The cells are small, spherical, and can 
occur in short chains, in pairs or individually. 
Results 
 
- 32 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15: Fluorescence micrographs of the untreated in situ oral biofilms on the Ma (left) and MS (right) Ti 
discs, a and b at 10 X magnification describe the ratio of the covered area on Ti discs, a1, a2, a3 and b1, b2, 
b3 at 100 X 10 magnifications exhibit different forms of bacteria, nuclei of keratinized cells and the ratio of 
green and red fluorescence 
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Fig. 16: Fluorescence micrographs captured with confocal laser microscope of the untreated control oral 
biofilms formed on the MS Ti discs, a1 and a2 are horizontal and lateral sections, b1-b4 are four sagittal   
sections from the bottom to the top. The lower sections showed only cocci form bacteria, while bacilliform 
bacteria become clear in the upper sections 
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Fig. 17: SEM micrographs of the untreated 72 h oral biofilms formed on the Ma (left) and MS (right) Ti 
discs, a1 and b1 at 50 X magnification describe the ratio of covered areas, a2 and b2 at 1000 X magnification, 
a3 and b3 at 10000 X magnification show the biofilm structure (Idlibi et al., 2013) 
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4.3.  Analysis of biofilm after treatment 
4.3.1. Live/dead staining 
- Machined titanium discs:  
The average percentage cover of green fluorescence on the UC, GC and AA was 90.04%, 
78.02% and 72.7%, respectively. Two out of the five Ti discs after the treatment with AA did 
not show residual biofilms. All CAP groups, DL, CHX1 and CHX2 resulted in a significant 
decrease in the percentage cover of green fluorescence, in comparison with UC (CAP1 
15.11%, CAP2 38.6%, CAP3 35.96%, CAP4 35.13%, DL 8.15%, CHX1 13.76%, and CHX2 
12.18%, p = 0.0 for all comparison). The average percentage cover of green fluorescence after 
the treatment with CAP1 differed significantly from CAP2, CAP3, and CAP4 (p < 0.05, Table 
5-2b), whereas no significant difference was observed between CAP2, CAP3, and CAP4 
(p > 0.05, Table 5-2b). No significant difference was observed between CAP1 and CHX2 
(p = 0.626), while DL and CHX1 differed significantly from CAP3 (p < 0.05, Table 5-3). 
  
  
 
 
 
 
 
 
 
 
 
Fig. 18: Average percentage (mean and 95 % confidence intervals) of green fluorescence on the Ma Ti discs 
determined after the various treatments of the in situ biofilms. Fivefold determination (Idlibi et al., 2013) 
Fig. 19: Fluorescence micrographs of the Ma Ti discs at 1000 X magnification a: UC, b: GC 
(Idlibi et al., 2013) 
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Fig. 21: Fluorescence micrographs of the Ma Ti discs at 1000 X magnification, a: DL, b: AA, c: CHX1, 
d: CHX2. Notice an increase in the proportion of red fluorescence after the treatment with DL and CHX, 
and a decrease in the amount of biofilms after the treatment with AA (Idlibi et al., 2013) 
Fig. 20: Fluorescence micrographs of the Ma Ti discs at 1000 X magnification, a: CAP1, b: CAP2, c: CAP3, 
d: CAP4. Notice an increase in the proportion of red fluorescence (Idlibi et al., 2013)  
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- Microstructured titanium discs:  
The average percentage cover of green fluorescence on GC (75.5%) and AA (68.79%) did not 
differ significantly (p < 0.05, Table 6-1) from UC (82.55%). All CAP experimental groups, 
DL, CHX1 and CHX2 resulted in a significant decrease of green fluorescence compared to 
UC (CAP1 13.95%, CAP2 24.74%, CAP3 33.41%, CAP4 36.76%, DL 8.48%, CHX1 7.36%, 
and CHX2 3.96%, p = 0.00 for all comparisons, Table 6-1).The lowest recorded percentage 
cover of green fluorescence was achieved by treatment with CHX2 (3.96%), only one of the 
five replicates did not show any green fluorescence from residual biofilms.  
The average percentage cover of green fluorescence after treatment with CAP1 did not differ 
significantly from CAP2 and CAP3 (p < 0.05), while differed significantly from CAP4 
(p = 0.037, Table 6-2b). No significant difference was observed between CAP1 and CHX2 
(p = 0.078), while DL and CHX1 differed significantly from CAP3 (p < 0.05, Table 6-3). 
 
 
 
 
  
 
 
 
 
 
 
Fig. 22: Average percentage (mean and 95 % confidence intervals) of green fluorescence of biofilms on 
the MS Ti discs determined after the various treatments of the in situ oral biofilms. Fivefold determination
Fig. 23: Fluorescence micrographs of the Ma Ti discs at 1000 X magnification a: UC, b: GC 
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Fig. 24: Fluorescence micrographs of the MS Ti discs at 1000 X magnification, a: CAP1, b: CAP2, c: CAP3, 
d: CAP4. Notice an increase in the proportion of red fluorescence after the treatment with CAP 
Fig. 25: Fluorescence micrographs of the MS Ti discs at 1000 X magnification, a: DL, b: AA, c: CHX1,    
d: CHX2. Notice an increase in the proportion of red fluorescence after the treatment with DL and CHX, 
and a decrease in the amount of biofilms after the treatment with AA  
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4.3.2. Microbiology 
- Machined titanium discs:  
All contact inoculation of UC and GC showed bacterial growth covering the entire impression 
area for all replicates (Figs. 26 and 27, Table 7). No bacterial growth was detected on any of 
the inoculated areas after the treatment with CAP1 and CAP3 (Figs. 26-3 and 26-5). One of 
the five replicates of CAP4 and CHX2 showed bacterial growth with an area of 0.33% and 
2.51%, respectively (Figs. 26-6 and 26-10). Four of the five inoculated areas on blood agar 
showed bacterial growth after the treatment with CAP2, DL, AA and CHX1, with an average 
coverage by microbial growths of 2.59%; 2%; 3.71%, and 15.49%, respectively                
(Figs. 26-4; 26-7, 26-8, and 26-9). The results after the treatment with CAP1 and CAP3 
differed significantly from CAP2 (p = 0.021, Table 7-2b). No significant difference was 
observed between CAP1 and CHX2 (p = 0.347) and between CAP3 and CHX1 (p = 0.322), 
while CAP3 differed significantly from DL (p = 0.023, Table 7-3). 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Average percentage of colony areas grew on blood agar after inoculation with the Ma Ti Discs 
determined after the various treatments of the in situ formed biofilms. Fivefold determination           
Fig. 26: Photographs of contact areas on the blood agar of the Ma Ti discs. 1: UC; 2: GC; 3: CAP1;   
4: CAP2; 5: CAP3; 6: CAP4; 7: DL; 8: AA; 9: CHX1; 10: CHX2. Notice the microbial growth on the 
blood agar of 1, 2, 4, 7, 8 and 9. (Idlibi et al., 2013)
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- Microstructured titanium discs:  
All contact inoculation of UC and GC showed bacterial growth covering the entire impression 
area for all replicates (Figs. 28-1 and 28-2). No bacterial growth was detected on any of the 
five inoculated areas after the treatment with CAP1, CAP3, and CAP4 (Figs. 28-3, 28-5, and 
28-6). Three replicates of CAP2 showed bacterial growth with colony area of 4.4%         
(Figs. 28-4). All inoculated areas after the treatment with DL, AA, CHX1, and CHX2 showed 
microbial growth with an average coverage of 8.43%, 21.74%, 52.5%, and 13.7%, 
respectively (Figs. 28-7, 28-8, 28-9, and 28-10). The results after the treatment with CAP1, 
CAP3 and CAP4 differed significantly from CAP2 (p < 0.05 for all comparisons, Table 8-2b). 
Also CAP1 differed significantly from CHX2 (p = 0.006), and CAP3 from CHX1 (p = 0.003), 
while no significant difference was observed between CAP1 and DL (p = 0.129, Table 8-3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Photographs of contact areas on the blood agar of the MS Ti discs. 1: UC; 2: GC; 3: CAP1; 4: 
CAP2; 5: CAP3; 6: CAP4; 7: DL; 8: AA; 9: CHX1; 10: CHX2. Notice growing of the bacteria on the 
blood agar of 1, 2, 4, 7, 8, 9 and 10 
Fig. 29: Average percentage of colony areas grew on blood agar after inoculation with the MS Ti Discs 
determined after the various treatments of the in situ formed biofilms. Fivefold determination
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4.3.3. Detection of total protein 
- Machined titanium discs:  
All experimental parameters of CAP, DL and AA led to a significant reduction in the amount 
of protein, compared with UC (p < 0.05, Table 9-1). The mean values of residual protein after 
the treatment with CAP groups 1-4 were 6.29 µg, 11.14 µg, 11.14 µg, and 13.44 µg,          
respectively. Three of the five Ti discs, treated with AA, had levels of protein below           
detection, while the remaining two replicates showed a mean residual protein of 0.83 µg. The 
gas treatment and submersion of the Ti discs in chlorhexidine for 60 s (CHX1) and for 200 s 
did not significantly decrease the total amount of protein, compared with UC (p > 0.05, Table 
9-1); the mean values of residual protein were 20.2 µg for GC, 16.62 µg for CHX1 and 
15.06 µg for CHX2. 
No significant differences were observed in the amount of the residual biofilms between CAP 
parameters (p > 0.05 for all comparisons, Table 9-2b). Also no significant differences were 
observed between CAP3 and DL (p = 0.384), while AA differed significantly from CAP3 
(p = 0.002, Table 9-3). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30: Average protein amounts (mean and 95 % confidence intervals) determined after the various         
treatments of the in situ oral biofilms formed on the Ma Ti discs. Fivefold determination (Idlibi et al., 2013) 
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- Microstructured titanium discs:  
All experimental parameters of CAP, DL, AA, and CHX2 led to a significant reduction in the 
amount of protein, compared with UC (p < 0.05, Table 10-1). The mean values of residual 
protein after the treatment with CAP parameters were 15.71 µg, 21.31 µg, 32.5 µg, and 
34.26 µg. Two of the five replicates, treated with AA, had levels of protein below detection, 
while the remaining three replicates showed a mean residual protein of 2 µg (p = 0.00). 
Calculations of the amount of protein after the treatment with DL resulted in the mean value 
of 24.49 µg. The submersion of the Ti discs in CHX for 60 s (CHX1) did not lead to 
significant decreases in the total amount of protein; mean value: 39.04 µg and p = 0.051, 
while the submersion for 200 s (CHX2) led to the mean value of protein 34.04 µg and differed 
significantly from UC (p = 0.006). No significant difference was observed after the treatment 
with GC (p = 0.684), in comparison with UC; the mean value reached 51.66 µg (Table 10-1). 
No significant difference was observed in the amount of the residual protein between CAP1 
and CAP2 (p = 0.905), or between CAP3 and CAP4 (p = 1), while CAP1 differed 
significantly from CAP3 (p = 0.044) and CAP4 (p = 0.023, Table 10-2b). No significant 
difference was observed between CAP3 and DL (p = 0.327), while AA differed significantly 
from CAP3 (p = 0.00, Table 10-3).  
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Fig. 31: Average protein amounts (mean and 95 % confidence intervals) determined after the various 
treatments of the in situ formed biofilms on the MS Ti discs. Fivefold determination 
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4.3.4. Scanning electron microscope 
- Ma and MS titanium discs: 
The SEM images of the UC showed a predominance of coccoid-shaped bacteria and the   
presence of rod-shaped bacteria (Figs. 32-a, 33-a). All the Ti discs, treated with CAP, showed 
degradation of the structure of the biofilms, reduced amounts of biofilm, and a substantial 
decrease in the  number of bacteria in the superficial layer (Figs. 34-35). The greatest effect 
was observed after the treatment with CAP1 (Figs. 34-a, and 35-a), while no substantial    
difference was apparent between the other CAP treatments (Figs. 34 b-d, and 35 b-d). DL led 
to a decrease in the amount of biofilms (Figs. 36-a, and 37-a). The greatest efficacy was    
observed after the treatment with AA; low magnification (X 50) gave the impression that the 
Ti discs were completely cleaned, but at higher magnification (X 10000) small bacterial     
colonies spread on the surface of the specimen could be observed (Figs. 36-b, and 37-b). The 
Ti discs, treated with CHX1 and CHX2, showed rarefication in the biofilm matrix and            
a decrease in the bacteria in the superficial layer (Figs. 36 c-d, and 37 c-d). The GC did not 
show any alterations in the amount of bacteria or the biofilm structure (Figs. 32-b, and 33-b). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: SEM micrographs of the Ma Ti discs at 10000 X magnification, a: UC, b: GC (Idlibi et al., 2013) 
Fig. 33: SEM micrographs of the MS Ti discs at 10000 X magnification, a: UC, b: GC  
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Fig. 34: SEM micrographs of the Ma Ti discs at 10000 X magnification, after the treatment 
with a: CAP1, b: CAP2, c: CAP3, d: CAP4 (Idlibi et al., 2013) 
Fig. 35: SEM micrographs of the MS Ti discs at 10000 X magnification, after the treatment 
with a: CAP1, b: CAP2, c: CAP3, d: CAP4 
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Fig. 36: SEM micrographs of the Ma Ti discs at 10000 X magnification after the treatment 
with a: DL, b: AA, c: CHX1, d: CHX2 (Idlibi et al., 2013) 
Fig. 37: SEM micrographs of the MS Ti discs at 10000 X magnification after the treatment 
with a: DL, b: AA, c: CHX1, d: CHX2 (Idlibi et al., 2013) 
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4.4. Temperature monitoring  
The surface temperature increased instantaneously and reached the maximum in the plasma 
jet's center within five seconds. Increase of the surface temperature during the CAP treatment 
correlated with the presence of biofilms on the Ti discs, increase of the surface roughness, and 
mean power (Figs. 38 and 39, Tables 11, 12, and 13).  
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Fig. 38: Mean temperature values on the upper surfaces of the clean and contaminated Ma Ti 
discs during the treatment with cold atmospheric plasma 
Fig. 39: Mean temperature values on the upper and the lower surfaces of the clean and contaminated 
MS Ti discs during the treatment with cold atmospheric plasma 
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4.5. Effects of cold plasma on the surface structure of titanium surfaces 
The SEM examination failed to demonstrate any visible morphological differences between 
the CAP-treated and control-untreated Ma and MS Ti surfaces. In particular, no thermal side 
effects, such as melting or loss of the porosity, were observed (Figs. 40 and 41). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 41: SEM micrographs of the MS Ti discs at 10000 X magnification; a1: control untreated; a2: is the 
same area after treatment with CAP1. b1: control untreated; and b2: is the same area after treatment with 
CAP2 
Fig. 40: SEM micrographs of the Ma Ti discs at 10000 X magnification; a: control untreated and 
b: after treatment with CAP1 
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5. Discussion 
The present experimental investigation has demonstrated that cold atmospheric plasma is 
suitable for inactivating and destroying the three-day in situ oral biofilms formed on the 
machined and microstructured titanium discs at acceptable temperatures, without causing any 
damage to titanium surfaces. The efficacy of CAP was evaluated at two different mean 
powers, two different gas mixtures, and two different treatment durations. The untreated 
biofilms as negative control and the treated biofilms groups (diode laser, air-abrasion, and 
chlorhexidine) as positive controls were used to estimate the efficacy of CAP.  
All plasma parameters exhibited great abilities to inhibit bacterial growth on blood agar and 
resulted in a significant decrease in the total amount of biofilms and the average percentage of 
viable bacteria, compared with the untreated control. There was a correlation between 
increasing the effectiveness of plasma and increasing the mean power and/or treatment 
duration. The antiseptic efficacy of CAP was comparable with diode laser and chlorhexidine.  
5.1 Titanium specimens and the biofilm formation  
The used Ti discs in the current study represent the most prevalent types of implant surfaces. 
The first is machined, typifying the supragingival part of dental implants which is usually 
used to prevent the formation of oral biofilms. The second is microstructured, typifying the 
subgingival part of dental implants which is used to enhance the osseointegration between 
bone and implant surfaces. The microstructure of the Ti discs had a mean roughness of 2 µm, 
with a maximum measured distance between the highest and the lowest level of 21 µm.  
The volunteers adapted their oral hygiene to create reproducible amounts of viable biofilms 
like those that accumulate around dental implants in the oral cavity. They stopped using 
mouth rinses two weeks before the study started. The oral hygiene measures were carried out 
without using toothpastes and no brushing of the Ti discs. The Ti discs were positioned 
ca. 1 mm deeply in the silicon impression material to avoid any self-cleaning movement that 
may happen by contacts with cheek mucosa (Fig. 1). The splints were removed from the oral 
cavity during brushing, eating, and drinking. Moreover, biofilm inhibiting drinks, such as 
wine or tea, were avoided (Rupf et al., 2011; Idlibi et al., 2013).  
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5.2 Analysis methods 
Two methods were used to check the viability of biofilms: The first being the live/dead 
staining technique that allowed living and dead bacteria to be distinguished quantitatively. 
The kit consists of two nucleic acid stains: green (SYTO9) and red (propidium iodide). These 
stains differ in their abilities to penetrate bacterial cell membranes and stain nucleic acids. 
Acids green fluorescing is able to enter all cells, while the red fluorescing only enters cells 
with damaged cytoplasmic membranes and can reducing SYTO®9 fluorescence when both 
dyes are present. Thus, live bacteria with intact membranes have only SYTO®9 and will 
fluoresced green, while dead bacteria with damaged membranes have the both dyes but 
fluoresce red. Despite the fact that this technique can be applied rapidly and gives an idea of 
viability changes, there are some limitations which should be taken into consideration: (1) 
Bacteria in intermediate states, represented by dormant or prelytic cells, may appear green, 
but are not viable or cultivable. Additionally, staining of bacterial cells does not always 
produce distinct “green” and “red” populations. It may make difficult the interpretation of 
results (Berney et al., 2007); (2) It is quite simple to picture separate bacteria on plane 
surfaces, but quantitative interpretation of images becomes increasingly difficult with 
irregular surfaces containing numerous numbers of compact bacterial aggregates, as is the 
case in this study of natural biofilms formed in situ; and (3) The kit stains both DNA and 
RNA. Non-bacterial components, such as eukaryotic cells, are therefore also stained green or 
red (Berney et al., 2007). In conclusion, it can be assumed that red fluorescence represents 
non-viable bacteria; however, it is not necessarily true that all green fluorescence indicates 
viable bacteria. Therefore, it seems appropriate to use another technique to investigate the 
viability of bacteria in the residual biofilms. For this purpose, contact inoculation of control 
and the treated specimens were performed on blood agar, a non-selective growth medium, 
thereby providing a complete nutrient environment for microbes and supporting the growth of 
a wide range of organisms. 
The detection of total protein was used to define the amount of the residual biofilm and to 
estimate the ability of the technique to eliminate the oral biofilms. SEM was used to 
investigate the presence of biofilms or the cleanliness of the specimens, as well as to 
investigate morphological changes in the residual biofilm. 
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5.3 Three-day in situ oral biofilms grown on titanium surfaces 
All the volunteers showed similar colonization patterns of Streptococcus mitis, Streptococcus 
gordonii, Streptococcus constellatus, Actinomyces odontolyticus, Actinomyces viscosus, 
Fusobacterium nucleatum, Viellonella parvula, Eikenella corrodens and Capnocytophaga on 
the Ma and MS Ti surfaces. The Streptococci were always the predominant colonizing 
microbes, Actinomyces species and Streptococci are considered to be early colonizers on 
intraoral hard tissues which prepare the environment for the adhesion and growth of late 
colonizers. Veillonella spp. are anaerobic gram-negative cocci and considered to be early 
colonizers of the normal oral human flora. Fusobacterium nucleatum has been reported to be 
a late colonizer that is only prominent in dental plaques after early colonizers are settled on 
the teeth (Socransky & Haffajee, 1998; Foster & Kolenbrander, 2004; Al-Ahmad et al., 
2010). 
No differences in composition were observed between the biofilms accumulated on the Ma or 
MS Ti surfaces in relation to the colonization of the investigated bacteria. Our results are in 
agreement with previous observations which showed no significant differences in biofilm 
composition formed on different implant surfaces, or between the biofilms formed on implant 
surfaces and intra-oral hard tissues (Al-Ahmad et al., 2010; Foster & Kolenbrander, 2004).  
The personal factor and the roughness of Ti discs played a large role in determining the 
amount of the accumulated biofilms. Results of protein detection showed significant 
differences in the amount of the accumulated biofilms between volunteers; p = 0.001 of the 
Ma Ti discs and p = 00 of the MS Ti discs. Results of protein analysis showed a significantly 
higher biofilm accumulation on the MS Ti discs than on the Ma Ti discs p = 0.0003 (Fig. 14). 
According to the SEM examination, all the MS Ti discs were entirely filled up with biofilms 
and the biofilms were even visually detectable after air drying without optical enlargement, 
while the covered areas on the Ma Ti discs ranged between 60-100%. These results are 
consistent with other in vivo studies, which have reported a close relationship between the 
surface roughness and accumulation of dental plaques (Nakazato et al., 1989; Quirynen et al., 
1989 and 1990; Quirynen et al., 1993; Bollen et al., 1997; Rimondini et al., 1997; Al-Ahmad 
et al., 2010; Bürgers et al., 2010). The rough and irregular surfaces create a safe haven for the 
microorganisms which are to be more protected against shear forces. Furthermore, they 
increase the potential area for bacterial adhesion (Nyvad and Fejerskov, 1987). 
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5.4 Decontamination of titanium discs 
Incomplete removal of biological contamination, including plaque biofilm and bacteria, is 
considered one of the most important factors that may affect the healing of peri-implant 
diseases after conservative or regenerative therapy. To the best of our knowledge, no available 
study has evaluated the efficacy of helium cold atmospheric plasma to remove and kill in situ 
oral biofilms formed on Ti surfaces. The efficacy of all treatment techniques, which were 
compared in this study, differed according to their respective abilities to remove oral biofilms, 
their bactericidal properties, or both. 
All CAP parameters accomplished a significant reduction of green fluorescence percentage on 
the Ma and MS Ti discs, compared with the UC (p < 0.05) (Tables 5-1 and 6-1, Figs. 18, 20, 
22, and 24). The average percentage of residual green fluorescence on the Ma Ti discs is 
inversely related to the increase of mean power and treatment duration. The greatest effect on 
the Ma Ti discs was achieved after the treatment with CAP1, which differed significantly 
from CAP2, CAP3, and CAP4 (p < 0.05, Tables 5-2a and 5-2b). No significant differences 
were observed between CAP2 and CAP3, or between CAP2 and CAP4, in spite of the 
differences in treatment duration (Table 5-2b). On the MS Ti discs, CAP1 showed more 
capacity to dead biofilm as CAP2 or CAP3, but the differences between the groups were not 
significant (p > 0.05, Table 6-2b). 
The lowest percentage of green fluorescence was recorded after treatment with DL (60 s) on 
the Ma Ti discs, and CHX2 (200 s) on the MS Ti discs. The results showed that CAP1 (196 s) 
is comparable with CHX2 (200 s) in its effect against oral biofilms on the Ma Ti discs, no 
significant differences between the treatments were observed (p > 0.05, Table 5-3).           
Conversely, DL (60 s) and CHX1 (60 s) have more efficacy than CAP3 (49 s) in reducing 
green fluorescence on the Ma and MS Ti discs (p < 0.05, Tables 5-3 and 6-3).  
The results of blood agar inoculation revealed no bacterial growth after treatment with CAP1 
and CAP3 of the Ma and MS Ti discs. Only one of the five trials of CAP4, with the Ma Ti 
discs, displayed bacterial growth in a small area, while all trials of the MS Ti discs were   
negative. On the other hand, CAP2 showed bacterial growth on four impression areas of the 
Ma Ti discs and all agar inoculation of the MS Ti discs, but all the colonies were small and 
their areas did not exceed 2.6% on the Ma Ti discs and 3.8% on the MS Ti discs                 
(Tables 7-1 and 8-1).  
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On the basis of microbiology results, we can conclude that the residual green fluorescence, 
after the treatment with CAP parameters, did not exhibit proliferation capability, excluding a 
little amount of bacteria after the treatment with CAP2. If we exclude the single positive 
specimen of CAP4 on the Ma Ti discs, we can report that all biofilms treated with 5 W did not 
display any bacterial growth on blood agar. Also, CAP3 with 49 s of treatment duration was 
enough to attain the same efficacy level as CAP1 with the treatment duration of 196 s (Tables 
7-1 and 8-1). The results of inoculation on blood agar after the treatment with CAP showed 
no differences between the Ma and MS Ti discs, in spite of the MS Ti discs having more 
amounts of accumulated biofilms (the amount of biofilm accumulated on the MS discs 
reached approximately twice the amount on Ma discs).  
The results showed that CAP1 (196 s) was comparable to CHX2 (200 s), and CAP3 was 
comparable to CHX1 (60 s) and DL (60 s) in their effects on the Ma and MS Ti discs (Tables 
7-3 and 8-3). According to microbiology results, CAP produced the best results with regard to 
the inhibition growth of oral microorganisms on blood agar. 
The results of colorimetric determination showed that all the tested CAP parameters on the 
Ma and MS Ti discs, compared to UC, led to a significant reduction in the amount of 
biofilms, but in different proportions (Tables 9-1 and 10-1, Figs. 30 and 31). The comparison 
of the amount of residual protein on the MS Ti discs indicated an association between the 
effectiveness of CAP with increases in the treatment duration, which led to more biofilm 
elimination as is evident by comparing CAP1 with CAP3, or CAP1 with CAP4. The removed 
amount of biofilm by CAP1 was approximately two times more than the amount removed by 
CAP3 on the Ma and MS Ti discs. CAP1 differed significantly from CAP3 on the MS Ti 
discs (p = 0.04). Increase of the mean power showed more capacity to decrease biofilm; the 
removed amount of biofilm by CAP1 was approximately twice as much as the amount of 
biofilm removed by CAP2 in the case of the Ma Ti discs, and approximately 30% in the case 
of the MS Ti discs. However, statistical comparison failed to find significant differences 
between CAP1 and CAP2 on the Ma or MS Ti discs (p > 0.05, Tables 9-2b and 10-2b). The 
admixture of oxygen to helium did not improve the effectiveness of CAP3, while no 
significant differences were observed between CAP3 and CAP4 on the Ma or MS Ti discs 
(p > 0.05, Tables 9-2b and 10-2b). 
There were no significant differences in the amount of residual protein between CAP3 (49 s) 
and DL (60 s) on the Ma or MS Ti discs (p > 0.05, Tables 9-3 and 10-3). AA was the best 
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effective cleaning method in the current study, three of the five replicates of the Ma Ti discs 
and two of the five replicates of the MS Ti discs had levels of protein below detection. AA 
differed significantly from CAP3 on the Ma and MS Ti discs (p < 0.05, Tables 9-3 and 10-3). 
Scanning electron microscopy analysis revealed distinct micro-morphological alterations of 
the adherent microorganisms and the biofilm matrix after the CAP treatment. All Ti discs 
showed destruction of biofilm structure and the amount of biofilm was reduced. The greatest 
effect was observed after the treatment with CAP1, then CAP2 (Figs. 34: a-b and 35: a-b), 
while no substantial difference was noticed between CAP3 and CAP4 (Figs. 34: c-d and 35: 
c-d). All plasma-treated groups were characterized by substantial decreases in the number of 
bacteria in the superficial layer of the residual biofilm. However, complete removal of 
biofilms from the Ti surfaces after plasma treatment could not be observed. CHX1 and CHX2 
groups showed rarefication in the biofilm matrix and decreases in the bacteria in the 
superficial layer (Figs. 36 c-d and 37 c-d). Gas control did not display alterations in the 
biofilm structure (Figs. 32b and 33b). The application of AA showed the best efficacy at 
removing oral biofilms; though the 50-fold magnification give an impression that the Ti discs 
were 100% clean, the 10000 fold magnification showed small bacterial colonies on the 
specimen surface. However, it was demonstrated that half of the specimens treated with AA 
showed viable residual biofilms (green fluorescence or bacterial growth on blood agar); 
treatments for 60 s were not always enough to achieve complete biofilm elimination (Figs. 
36-b and 37-b).  
The current results of cold atmospheric plasma are comparable with other in vitro studies. The 
application of atmospheric-pressure glow-discharge plasma led to the killing and inhibition of 
Streptococcus mutans cultured on the agar nutrient in petri dishes (Goree et al., 2006; Sladek 
et al., 2007). Tissue-tolerable plasma was found to be effective against Pseudomonas 
aeruginosa biofilms growth on polystyrene and silicone materials (Hübner et al., 2010). Rupf 
et al., (2010) evaluated the antimicrobial efficacy of non-thermal atmospheric plasma against 
adherent oral microorganisms (Escherichia coli, Lactobacillus casei, Streptococcus mutans, 
and Candida albicans) on agar plates and dentin slices. The plasma treatment of agar plates 
caused complete growth inhibition of Escherichia coli and Lactobacillus casei.                      
A time-dependent reduction of growth was observed on the irradiated surfaces for 
Streptococcus mutans. 
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Rupf et al., (2011) combined cold atmospheric plasma with air/water spray to investigate the 
disinfection and removal of in situ formed biofilms on the microstructured Ti discs. The Ti 
discs were exposed to human oral cavities from two volunteers for 24 and 72 h, 
respectively. The plasma treatment of biofilms was carried out ex vivo by using the same 
plasma source and working under the same conditions of the current study. The mean power 
was adjusted by setting the pulse frequency at 3 or 5 W with the treatment time as 196 s. 
Group (A) was treated only with plasma; while in the case of Group (B), after the plasma 
treatment, specimens were washed with air/water spray for 5 s. Group (C) was treated with 
plasma and washed with air/water spray, and then second plasma treatment was repeated. No 
microbial growth was detected on Rodac plates of any of the 24 h biofilm specimens on the Ti 
discs treated by cold atmospheric plasma, or in combination with air/water spray. In case of 
the 72 h biofilm samples, bacterial colonies were detected on two out of five Rodac culture 
plates after the first round of cold plasma at 3 W, and subsequent air/water spray treatment, 
and all other Rodac plates displayed no bacterial growth. Fluorescence microscopy and 
scanning electron microscopy analyses revealed distinct micromorphological alterations of 
the adherent microorganisms and the biofilm matrix. A strong decrease of biofilm viability 
(green fluorescence) and significant reductions in biofilm protein amounts were recorded for 
both 24 h and 72 h biofilms. Higher mean plasma power (5 W) resulted in the extended 
thinning of the biofilms. However, a treatment of biofilms with the plasma jet alone was not 
sufficient, under the chosen conditions, to achieve a complete removal of the biofilms. The 
plaque biofilm was disinfected and reduced in thickness with disintegration of the remnant 
biofilm structure, and superficial bacteria as well as most bacteria of the deeper biofilm layers 
were destroyed after the plasma treatment alone. Additional application of mechanical 
cleaning by the air/water spray, however, almost completely reduced the biofilm remnants. 
It can be concluded that the efficacy of cold atmospheric plasma was manifested through two 
relevant therapeutic effects: the first one is physical, caused by burning and devastation of the 
biofilm and its components (Manner 2008; Dobrynin et al., 2009), while the second one is 
biological and it results from reactive species such as oxygen and nitric radicals (Laroussi 
2002; Kieft et al., 2005; Vleugels et al., 2005). The physical effect was associated with an 
increase of mean power and treatment duration, and correlated with an increase of the      
eliminated biofilm and destructed bacteria. Consequently, the efficacy of CAP ranges         
between disinfection of microorganisms and removal of biofilm (Idlibi et al., 2013).  
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5.5 The mechanical and thermal effects of cold atmospheric plasma 
The SEM analysis of plasma-treated Ti discs failed to reveal any micromorphologically 
detectable changes of the machined or microstructured Ti surfaces. This does not exclude, 
however, the chemico-physical changes of the Ti surfaces due to the plasma application, 
including UV radiation, jet stream of chemical radicals and electrons leading to an increase in 
the hydrophilicity on the Ti surfaces (Yoshinari et al., 2010).  
The maximum surface temperature reached approximately 52 °C during the treatment of 
contaminated MS Ti discs with 5 W mean power (Table 12). The surface temperatures of the 
MS Ti discs were, in all cases, higher than the surface temperatures of the Ma Ti discs (clean 
or contaminated Ti discs). Also, the surface temperatures of the Ma or MS Ti discs during the 
treatment with 5 W were always higher than surface temperature during the treatment with 
3 W in all cases (Tables 11 and 12). It was observed that the surface temperatures of the 
contaminated Ti discs were always higher than the surface temperatures of the clean Ti discs 
at the same surface type and the same mean power (Tables 11 and 12). The surface 
temperatures of the clean Ti discs had approximate average values, while the measured 
temperatures on the contaminated Ti discs were disparate and had larger standard deviation 
values (Tables 11 and 12). These differences in the measured temperatures may be due to the 
presence of biofilms on the Ti discs and to the differences in the amount of the accumulated 
biofilms between the volunteers. 
Because of the high surface temperature during the treatment of the contaminated MS Ti discs 
with 5 W mean power, we have measured the surface temperature on the lower side of the 
contaminated MS Ti discs. The results approached the values recorded on the upper surfaces 
of the clean Ti discs that were treated with the same parameters. This indicates that the 
temperature recorded during the treatment with 5 W mean power of the contaminated MS Ti 
discs is not the temperature of the Ti discs, but the temperature of burning biofilms 
(Table 13).  
In any case, the available data regarding the thermal tolerance of peri-implant bone suggested 
a limit of 44 °C (Eriksson & Alberktsonn, 1984). The temperature at the jet contact point can 
be established, as shown by limiting the output below the critical temperature range. 
However, the potential damage to peri-implant tissue must be conducted before the plasma jet 
treatment is introduced to dental practice.  
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5.6 Conclusion 
Concerning these aspects, the plasma jet source used in the present study appears to be 
suitable to disintegrate the matured oral in situ biofilms formed on the machined and 
microstructured Ti surfaces without causing any thermal or mechanical damages. The 
comparison with other studies suggested that cold atmospheric plasma was comparable to 
diode laser and Chlorhexamed 0.2% in its antibacterial effects. Cold atmospheric plasma 
might be used alone, when there is no urgent need for mechanical decontamination, or after 
mechanical decontamination, to ensure disinfection.  
Further investigations are necessary to evaluate the potential use of cold atmospheric plasma 
under in vivo conditions and the combination of cold atmospheric plasma with other 
mechanical debridement methods such as plastic curettes, ultrasonic, or air-abrasion, as well 
as their possible role in the clinical setting to improve the re-osseointegration of implants. 
From a clinical point of view, it should also be taken into account that a large number of 
different implant types and surface characteristics complicate a generalization of the present 
results. 
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Removing biofilms from microstructural Ti ex vivo: a novel approach using atmospheric 
plasma technology 
Rupf S; Idlibi AN; Al-Marrawi F; Hannig M; Schubert A; von Müller L; Spitzer W; 
Holtmann H; Lehmann A; Rueppel A; Schindler A (2011) PloS ONE 6; e25893 
Abstract: 
The removal of biofilms from microstructured titanium used for dental implants is a still 
unresolved challenge. This experimental study investigated disinfection and removal of in situ 
formed biofilms from microstructured titanium using cold atmospheric plasma in combination 
with air/water spray. Titanium discs (roughness (Ra): 1.96 µm) were exposed to human oral 
cavities for 24 and 72 h (n = 149 each) to produce biofilms. Biofilm thickness was determined 
using confocal laser scanning microscopy (n = 5 each). Plasma treatment of biofilms was 
carried out ex vivo using a microwave-driven pulsed plasma source working at temperatures 
from 39 to 43 °C. Following plasma treatment, one group was air/water spray treated before 
re-treatment by second plasma pulses. Vital microorganisms on the titanium surfaces were 
identified by contact culture (Rodac agar plates). Biofilm presence and bacterial viability were 
quantified by fluorescence microscopy. Morphology of titanium surfaces and attached 
biofilms was visualized by scanning electron microscopy. Total protein amounts of biofilms 
were colorimetrically quantified. Untreated and air/water treated biofilms served as controls. 
Cold plasma treatment of native biofilms with a mean thickness of 19 µm (24 h) to 91 µm (72 
h) covering the microstructure of the titanium surface caused inactivation of biofilm bacteria 
and significant reduction of protein amounts. Total removal of biofilms, however, required 
additional application of air/water spray, and a second series of plasma treatment. 
Importantly, the microstructure of the titanium discs was not altered by plasma treatment. The 
combination of atmospheric plasma and non-abrasive air/water spray is applicable for 
complete elimination of oral biofilms from microstructured titanium used for dental implants 
and may enable new routes for the therapy of periimplant disease. 
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Disinfection and removal of biofilms on microstructured Ti by cold atmospheric plasma 
Rupf S; Idlibi AN; Umanskaya N; Hannig M; Nothdurft F; Lehmann A; Schindler A;  
von Müller L; Spitzer W (2012) Journal of Dental Implantology 2:126-137 
Introduction: Biofilms on dental implants play an important role in the genesis of 
inflammatory peri-implant disease. Decontamination of microstructured titanium is still a 
challenge for the dental practitioner. Cold atmospheric plasma jets offer disinfecting 
capabilities at biologically acceptable temperatures. This experimental study investigated 
disincentive and destructive effects of cold atmospheric plasma on oral biofilms formed 
in situ on microstructured titanium surfaces. 
Material and Methods: microstructured titanium discs (sandblasted/etched; n = 120) were 
exposed to the oral environment of two healthy volunteers for 24 h to produce biofilms. 
Plasma treatment was carried out by means of a meander like CC line by line scanning with a 
pulsed microwave driven (2.45 GHz) plasma jet (2.5 s/mm²; 2.0 l/min He; 3 W or 5 W 
microwave mean power). Following plasma treatment some Ti discs were air/water sprayed 
and subsequently subjected to a second plasma treatment. Non-irradiated biofilms; biofilms 
treated with chlorhexidine and microstructured titanium discs without biofilms served as 
controls. Disinfection of biofilms was assessed by contact agar samples (RODAC technique) 
and fluorescence microscopy (vital/dead staining). Biofilm morphology was visualized by 
scanning electron microscopy; biofilm coverage was measured by fluorescence microscopy. 
Total protein was quantified colorimetrically. 
Results: Depending on the plasma jet power the microstructured titanium surface temperature 
at the plasma contact point varied between 39 and 43 °C. After plasma treatment only; 
disintegration as well as reduction of biofilm viability and of total protein was observed. The 
additional application of air/water spray resulted in a further reduction of biofilm viability and 
of total protein. Fluorescence and protein amounts were reduced comparable to control Ti 
discs without biofilms after a second plasma treatment. The microstructured surface of the 
samples was not altered by plasma treatment. 
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Destruction of oral in situ biofilms on machined titanium surfaces by cold atmospheric 
plasma 
Idlibi AN; Al-Marrawi F; Hannig H; Lehmann A; Rueppell A; Schindler A; Jentsch H and 
Rupf S (2013) Biofouling 29:369-379  
Abstract: 
The decontamination of implant surfaces represents the basic procedure in the management of 
peri-implant diseases, but it is still a challenge. The study aimed to evaluate the degradation 
of oral biofilms grown in situ on machined titanium discs by cold atmospheric plasma (CAP). 
200 titanium discs were exposed to the oral cavities of five healthy human volunteers for 72 
h. The resulting biofilms were divided randomly between the following treatments: CAP 
(which varied in mean power, treatment duration, and/or the gas mixture), and untreated and 
treated controls (diode laser, air-abrasion, chlorhexidine). The viability, quantity, and       
morphology of the biofilms were determined by live/dead staining, inoculation onto blood 
agar, quantification of the total protein content, and scanning electron microscopy. Exposure 
to CAP significantly reduced the viability and quantity of biofilms compared with untreated  
control. The efficacy of treatment with CAP correlated with the treatment duration and 
plasma power. No single method achieved complete biofilm removal; however, CAP may 
provide an effective support to established decontamination techniques for treatment of    
peri-implant diseases. 
 
 
 
 
 
 
 
 
Publications and Acknowledgement 
 
- 81 - 
7.2 Short lectures  
Biofilm Removal from Ti Surfaces by Non-Thermal Atmospheric Plasma-Jet               
(24 Stunden in situ oralen Biofilmen) 
Rupf S; Idlibi AN; Lehmann A; Rueppell A; Hannig M; and Schindler A 
International Association for Dental Research (IADR) (Barcelona 2010) 
Biofilm destruction of early biofilms on microstructured Ti by cold atmospheric plasma 
(24 Stunden in situ oralen Biofilmen) 
Rupf S; Idlibi AN; Umanskaya N; Hannig M; Nothdurft F; Lehmann A; Schindler A; Müller 
L; Spitzer W 
25. Jahrestagung der deutsche Gesellschaft für Implantologie (Dresden 2011) 
Destruktion und Entfernung von Biofilmen auf mikrostrukturierten Titanoberflächen 
mit kaltem atmosphärischem Plasma (72 Stunden in situ oralen Biofilmen) 
Idlibi AN.; Al-Marrawi F.; Hannig M.; Schindler A.; Rupf S 
Jahrestagugng der deutsche Gesellschaft für Parodontologie (Baden-Baden 2011) 
Destruktion und Entfernung von Biofilmen auf maschinierten Titanoberflächen mit 
kaltem atmosphärischem Plasma (72 Stunden in situ oralen Biofilmen) 
Idlibi AN; Al-Marrawi F; Hannig M; von Müller L; Rueppell A; Schindler A; Rupf S 
Deutscher Zahnärztetag (Frankfurt 2011) 
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9. Appendix 
 
Table 5: Live/dead staining (Ma Ti discs) 
Table 5-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
t-test for Equality of Means 95% Confide Interval 
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 90.03 4.15 1.86  
GC 5 78.02 8.01 3.59 UC-GC 2.98 8 0.018 12.01 4.04 2.71 21.32 
CAP1 5 15.11 8.32 3.72 UC-CAP1 18.03 8 0.000 74.93 4.16 65.34 84.51 
CAP2 5 38.6 4.53 2.03 UC-CAP2 18.73 8 0.000 51.44 2.75 45.11 57.77 
CAP3 5 35.96 6.07 2.72 UC-CAP3 16.44 8 0.000 54.08 3.29 46.5 61.66 
CAP4 5 35.13 14.66 6.56 UC-CAP4 8.06 8 0.000 54.91 6.82 39.2 70.63 
DL 5 8.15 11.38 5.09 UC-DL 15.12 8 0.000 81.89 5.42 69.4 94.37 
AA 3 72.7 7.025 4.06 UC-AA 4.49 8 0.004 17.34 3.86 7.9 26.78 
CHX1 5 13.76 11.46 5.12 UC-CHX1 13.99 8 0.000 76.28 5.45 63.72 88.85 
CHX2 5 12.18 9.94 4.45 UC-CHX2 16.16 8 0.000 77.86 4.82 66.75 88.97 
 
Table 5-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 1758.22 3 586.07 6.86 0.003 
Within Groups 1366.23 16 85.39   
Total 3124.45 19    
 
Table 5-b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1
95% Confidence Interval 
Lower Bound  Upper Bound 
CAP1 
CAP2 -23.49 5.84 0.006 -41.01 -5.96 
CAP3 -20.85 5.84 0.015 -38.37 -3.33 
CAP4 -20.01 5.84 0.021 -37.54 -2.5 
CAP2 
CAP3 2.64 5.84 0.998 -14.89 20.16 
CAP4 3.47 5.84 0.993 -14.05 21 
CAP3 CAP4 -0.84 5.84 1.000 -16.69 18.36 
 
Table 5-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3- CHX1 3.830 8 0.005 22.21 5.8 8.83 35.58 
CAP3- DL 4.822 8 0.001 27.81 5.77 14.51 41.11 
CAP1- CHX2 5.407 8 0.626 2.93 5.98 -10.43 16.3 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: Standard Error; M Diff: Mean Difference; SE 
Diff: Standard Error Difference. 
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Table 6: Live/dead staining (MS Ti discs) 
Table 6-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
t-test for Equality of Means 95% Confide Interval  
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 82.55 11.39 5.09  
GC 5 75.5 2.42 1.08 UC-GC 1.35 8 0.213 7.05 5.21 -4.96 19.06 
CAP1 5 13.95 10.36 4.63 UC-CAP1 9.96 8 0.00 68.60 6.88 52.72 84.48 
CAP2 5 24.74 12.80 5.73 UC-CAP2 7.54 8 0.00 57.81 7.67 40.14 75.49 
CAP3 5 33.41 9.3 4.16 UC-CAP3 7.47 8 0.00 49.14 6.58 33.97 64.31 
CAP4 5 36.76 13.01 5.82 UC-CAP4 5.92 8 0.00 45.79 7.73 27.96 63.62 
DL 5 8.48 6.16 2.75 UC-DL 12.79 8 0.00 74.07 5.79 60.72 87.42 
AA 3 68.79 6.31 3.64 UC-AA 1.87 8 0.108 13.76 7.3 -4.09 31.61 
CHX1 5 7.36 4.77 2.13 UC-CHX1 13.62 8 0.00 75.19 5.52 62.45 87.92 
CHX2 5 3.96 3.9 1.74 UC-CHX2 14.6 8 0.00 78.59 5.38 66.18 91.01 
 
Table 6-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 1557.76 3 519.25 3.94 0.028 
Within Groups 2108.13 16 131.76   
Total 3665.9 19    
 
Table 6-2b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1
95% Confidence Interval 
Lower Bound  Upper Bound 
CAP1 
CAP2 -10.79 7.26 0.641 -32.55 10.98 
CAP3 -19.46 7.26 0.095 -41.23 2.31 
CAP4 -22.81 7.26 0.037 -44.57 -1.04 
CAP2 
CAP3 -8.67 7.26 0.821 -30.44 13.09 
CAP4 -12.02 7.26 0.527 -33.79 9.74 
CAP3 CAP4 -3.35 7.26 0.998 -25.11 18.42 
 
Table 6-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3-CHX1 5.57 8 0.001 26.05 4.67 15.27 36.83 
CAP3-DL 5 8 0.001 24.93 4.99 13.43 36.44 
CAP1-CHX2 6.8 8 0.031 9.99 4.95 -1.42 21.4 
 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: standard Error; M Differ: Mean Difference; 
SE Differ: Standard Error Difference. 
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Table 7: Microbiology (Ma Ti discs) 
Table 7-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
t-test for Equality of Means 95% Confide Interval  
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 100 0.0 0.0  
GC 5 100 0.0 0.0 UC-GC unable to compare*2 
CAP1 5 0.0 0.0 0.0 UC-CAP1 unable to compare*2 
CAP2 5 2.59 2.28 1.02 UC-CAP2 95.49 8 0.0 97.41 1.02 95.05 99.76 
CAP3 5 0.0 0.0 0.0 UC-CAP3 unable to compare*2 
CAP4 5 0.33 0.74 0.33 UC-CAP4 302.03 8 0.0 99.67 0.33 98.91 100.43 
DL 5 2 1.60 0.72 UC-DL 136.80 8 0.0 98 0.72 96.35 99.65 
AA 3 3.71 4.39 1.96 UC-AA 49.05 8 0.0 96.29 1.96 91.76 100.82 
CHX1 5 15.49 32.82 14.68 UC-CHX1 5.76 8 0.0 84.51 14.68 50.67 118.36 
CHX2 5 2.50 5.60 2.51 UC-CHX2 38.90 8 0.0 97.49 2.51 91.72 103.27 
 
Table 7-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 23.50 3 7.83 5.45 0.009 
Within Groups 22.99 16 1.44   
Total 46.49 19    
 
Table 7-2b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1
95% Confidence Interval 
Lower Bound  Upper Bound 
CAP1 
CAP2 -2.56 0.76 0.021 -4.87 -0.32 
CAP3 0.0 0.76 1.000 -2.27 2.27 
CAP4 -0.33 0.76 0.999 -2.60 1.94 
CAP2 
CAP3 2.59 0.76 0.021 0.32 4.87 
CAP4 2.26 0.76 0.051 -0.01 4.54 
CAP3 CAP4 -0.33 0.76 0.999 -2.60 1.94 
 
Table 7-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3-CHX1 -1.01 8 0.322 -15.49 14.68 -49.33 18.36 
CAP3-DL -2.8 8 0.049 -2 0.716 -3.65 -0.35 
CAP1-CHX2 -1 8 0.347 -2.51 2.51 -8.29 3.27 
 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: Standard Error; M Differ: Mean Difference; 
SE Differ: Standard Error Difference. 
2 The standard deviations of both groups are zero. 
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Table 8: Microbiology (MS Ti discs) 
Table 8-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
t-test for Equality of Means 95% Confide Interval 
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 100 0.0 0.0  
GC 5 100 0.0 0.0 UC-GC unable to compare*2 
CAP1 5 00 0.0 0.0 UC-CAP1 unable to compare*2 
CAP2 5 4.37 4.86 2.17 UC-CAP2 44.01 8 0.0 95.63 2.17 90.62 100.64 
CAP3 5 0.0 0.0 0.0 UC-CAP3 unable to compare*2 
CAP4 5 0.0 0.0 0.0 UC-CAP4 unable to compare*2 
DL 5 8.32 10.98 4.91 UC-DL 18.67 8 0.0 91.68 4.91 80.36 102.99 
AA 3 21.74 16.89 7.55 UC-AA 10.36 8 0.005 78.26 7.55 60.85 95.68 
CHX1 5 52.49 27.46 12.28 UC-CHX1 3.87 8 0.0 47.51 12.28 19.19 75.83 
CHX2 5 13.70 8.15 3.65 UC-CHX2 23.68 8 0.0 86.3 3.65 77.89 94.70 
 
Table 8-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 71.68 3 23.89 4.05 0.026 
Within Groups 94.44 16 5.90   
Total 166.12 19    
 
Table 8-2b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1
95% Confidence Interval 
Lower Bound  Upper Bound 
CAP1 
CAP2 -4.37 1.54 0.048 -8.98 0.23 
CAP3 0.0 1.54 1.00 -4.61 4.61 
CAP4 0.0 1.54 1.00 -4.61 4.61 
CAP2 
CAP3 4.37 1.54 0.048 -0.24 8.98 
CAP4 4.37 1.54 0.048 -0.24 8.98 
CAP3 CAP4 0.0 1.54 1.00 -4.61 4.61 
 
Table 8-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3-CHX1 -4.27 8 0.003 -52.49 12.28 -80.81 -24.17 
CAP3-DL -1.7 8 0.129 -8.32 4.91 -19.64 2.99 
CAP1-CHX2 -3.759 8 0.006 -13.70 3.64 -22.11 -5.3 
 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: Standard Error; M Differ: Mean Difference; 
SE Differ: Standard Error Difference. 
2 The standard deviations of both groups are zero. 
 Appendix 
- 88 - 
Table 9: Detection of total protein (Ma Ti discs) 
Table 9-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
T-test for Equality of Means 95% Confide Interval 
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 22.17 5.12 2.29  
GC 5 20.2 1.08 0.48 UC-GC 0.84 8 0.424 1.97 2.34 -3.43 7.37 
CAP1 5 6.29 4.35 1.94 UC-CAP1 5.29 8 0.001 15.88 3 8.96 22.81 
CAP2 5 11.14 3.53 1.58 UC-CAP2 3.97 8 0.004 11.03 2.78 4.62 17.44 
CAP3 5 11.14 4.86 2.17 UC-CAP3 3.5 8 0.008 11.02 3.16 3.75 18.3 
CAP4 5 13.44 1.61 .719 UC-CAP4 3.64 8 0.007 8.73 2.4 3.2 14.27 
DL 5 8.46 4.35 1.94 UC-DL 4.54 8 0.002 13.71 3 6.78 20.63 
AA 3 0.83 1.13 0.51 UC-AA 9.1 8 0.0 21.34 2.35 15.93 26.75 
CHX1 5 16.62 4.09 1.83 UC-CHX1 1.83 8 0.095 5.55 2.93 -1.21 12.31 
CHX2 5 15.06 5.14 2.3 UC-CHX2 2.13 8 0.060 7.11 3.24 -0.37 14.59 
 
Table 9-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 135.92 3 45.31 3.15 0.054 
Within Groups 229.91 16 14.37   
Total 365.84 19    
 
Table 9-2b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1 
95% Confidence Interval 
Lower Bound Upper Bound 
CAP1 
CAP2 -4.85 2.4 0.310 -12.04 2.34 
CAP3 -4.86 2.4 0.309 -12.04 2.33 
CAP4 -7.15 2.4 0.052 -14.33 0.04 
CAP2 
CAP3 -0.004 2.4 1.000 -7.19 7.18 
CAP4 -2.3 2.4 0.926 -9.48 4.89 
CAP3 CAP4 -2.3 2.4 0.927 -9.48 4.9 
 
Table 9-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3 -DL 0.92 8 0.384 2.68 2.91 -4.03 9.41 
CAP3-AA 4.63 8 0.002 10.32 2.23 5.18 15.46 
 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: standard Error; M Differ: Mean Difference; 
SE Differ: Standard Error Difference. 
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Table 10: Detection of total protein (MS Ti discs) 
Table 10-1: Calculations of Means, standard deviations and standard error for all values. CAP-treated groups 
and positive controls (DL, AA, CHX) were compared with untreated controls by applying t-tests 
 
N M  S D S E 
t-test for Equality of Means 95% Confide Interval 
 t df Sig.1 M Diff. SE Diff. Lower  Upper  
UC 5 54.66 10.37 4.64  
GC 5 51.66 12.03 5.38 UC-GC 0.42 8 0.684 3 7.1 -13.38 19.38 
CAP1 5 15.72 7.85 3.51 UC-CAP1 6.7 8 0.0 38.94 5.82 25.53 52.35 
CAP2 5 21.30 5.11 2.29 UC-CAP2 6.45 8 0.0 33.36 5.17 21.44 45.28 
CAP3 5 32.54 10.92 4.88 UC-CAP3 3.29 8 0.011 22.12 6.73 6.59 37.65 
CAP4 5 34.26 9.72 4.34 UC-CAP4 3.21 8 0.012 20.4 6.36 5.74 35.06 
DL 5 24.48 13.38 5.98 UC-DL 3.99 8 0.004 30.18 7.59 12.73 47.63 
AA 3 2.02 1.96 .878 UC-AA 11.16 8 0.0 52.64 4.72 41.76 63.52 
CHX1 5 39.04 11.12 4.97 UC-CHX1 2.3 8 0.051 15.62 6.8 -0.05 31.29 
CHX2 5 34.04 6.7 3 UC-CHX2 3.74 8 0.006 20.62 5.52 7.89 33.35 
 
Table 10-2a: Multiple comparisons of CAP groups (One Way ANOVA) 
 Sum of Squares df Mean Square F Sig.*1
Between Groups 1193.8 3 397.93 5.28 0.01 
Within Groups 1206.11 16 75.38   
Total 2399.91 19    
 
Table 10-2b: Multiple comparisons of CAP groups (Sidak test) 
Group (I) Group (J) M Differ. (I-J) SE Differ. Sig. (2-tailed)1 
95% Confidence Interval 
Lower Bound Upper Bound 
CAP1 
CAP2 -5.58 5.49 0.905 -22.04 10.88 
CAP3 -16.82 5.49 0.044 -33.28 -0.36 
CAP4 -18.54 5.49 0.023 -35 -2.08 
CAP2 
CAP3 -11.24 5.49 0.299 -27.70 5.22 
CAP4 -12.96 5.49 0.174 -29.42 3.5 
CAP3 CAP4 -1.72 5.49 1.00 -18.18 14.74 
 
Table 10-3: Comparisons of CAP (CAP1/CAP3) with the positive controls (DL and CHX) by applying t-tests 
 t-test for Equality of Means 95% Confidence Interval  
t df Sig. (2-tailed)*1 Mean Differ. SE Differ. Lower  Upper  
CAP3 -DL 1.04 8 0.327 8.06 7.72 -9.74 25.87 
CAP3-AA 6.15 8 0.0 30.52 4.96 19.08 41.96 
 
                                                 
1 The mean difference is significant at the 0.05 level. 
N: Number of specimens; M: Mean; SD: Standard Deviation; SE: standard Error; M Differ: Mean Difference; 
SE Differ: Standard Error Difference. 
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Table 11: Measured temperatures on the upper surfaces of the clean and contaminated Ma Ti discs 
Cleaned 1 2 3 4 5 M SD 
CAP1 30.7 33 35.5 33.6 32.5 33.1 1.7 
CAP2 27.9 29.2 29 29 28.5 28.7 0.5 
CAP3 28.7 29.7 34.1 30.5 31.1 30.8 2.1 
CAP4 29.8 29.6 34 30 33 31.3 2 
Contaminated 1 2 3 4 5 M SD 
CAP1 42.8 42.8 35.4 35.4 36 38.5 4 
CAP2 34.1 34.1 32.6 32.6 32.7 33.2 0.8 
CAP3 36.3 36.3 40 40 38 38.1 1.8 
CAP4 34.7 34.7 43.9 43.3 31.6 37.6 5.6 
 
 
Table 12: Measured temperatures on the upper surfaces of the clean and contaminated MS Ti discs 
Cleaned  1 2 3 4 5 M SD 
CAP1 34.7 38.8 37.6 36.2 37.7 37 1.6 
CAP2 33.8 33.6 32.9 33.6 32.1 33.2 0.7 
CAP3 34.6 33.2 38.8 34.7 35.1 35.3 2.1 
CAP4 35.4 38.8 37.9 37.2 37 37.3 1.3 
Contaminated  1 2 3 4 5 M SD 
CAP1 56 45.8 52.7 56 50.9 52.3 4.2 
CAP2 34 38.4 41.8 41 35.3 38.1 3.4 
CAP3 50.4 41 52.2 52.8 57.8 50.8 6.2 
CAP4 50.5 40.1 55.1 54.4 51.9 50.4 6.1 
  
 
Table 13: Measured temperatures on the lower surfaces of the contaminated MS Ti discs 
MS 1 2 3 4 5 M SD 
CAP1 31.6 34 35.4 33.1 34.1 33.6 1.9 
CAP2 32.6 30 30 31.6 31 30.8 1.5 
CAP3 32.6 33.1 34.3 34.1 32.9 33.3 0.9 
CAP4 33.3 34.4 33.5 34.6 34.1 33.7 0.6 
 
